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Portfolio Thesis Abstract 
 
Introduction 
This thesis has two aims.  The first was to systematically review the literature on the effect 
of computer assisted cognitive remediation (CACR) for schizophrenia on psychosocial 
functioning, with a focus on methodological quality and efficacy.  The second aim was to 
evaluate the implementation of CACR in a high secure forensic setting. 
 
Method 
Database searches and hand searches returned 16 randomised controlled trials of CACR 
that included a functional outcome measure.  These were reviewed against predefined 
quality criteria and effect sizes were calculated.  In addition, an uncontrolled pre-post test 
design was used to evaluate the implementation of CACR in a high secure forensic hospital.  
Attrition rates, predictors of attrition, and participant feedback were evaluated, along with 
symptom and functional outcomes. 
 
Results 
The systematic review found a range of methodological limitations.  Studies that did not 
share these limitations did not provide evidence that CACR improves psychosocial 
functioning.  However, CACR may be effective in improving functional outcomes when 
delivered alongside interventions targeting functional skills.  The experimental study found 
a high attrition rate; poor adherence to the treatment protocol; no clinical, risk or 
demographic factors to distinguish treatment completers from those dropping out during 








The systematic review indicates that more methodologically rigorous research is required.  
Future studies with a general psychiatric population should examine the effect of CACR 
delivered in conjunction with interventions that aim to develop functional skills.  
Motivational deficits may have undermined the outcomes of the experimental study and it 
will be important to ensure the delivery of CACR in forensic psychiatric settings is designed 
to incorporate strategies for enhancing motivation.  In addition, using CACR to target 
functional outcomes may be inappropriate within a high secure forensic setting.  The role of 
CACR as in managing risk and enhancing the outcomes of other interventions should be 
explored. 
 





Chapter 1: Systematic Review 
This chapter contains a systematic review of the literature on the effect of computer 
assisted cognitive remediation for schizophrenia on psychosocial functioning, with a focus 
on methodological quality and efficacy.  It was written according the author guidelines for 
the Journal of Psychiatric Research, which can be found in Appendix 1.1. 
 




Systematic Review Abstract 
 
Title: Improving Functional Outcomes in Schizophrenia with Computer Assisted Cognitive 
Remediation: A systematic review of effect sizes and methodology 
 
Background: Computer assisted cognitive remediation therapy (CACR) has been developed 
in response to the recognition that problems with psychosocial functioning in people 
diagnosed with schizophrenia are related to deficits in cognitive functioning.  A previous 
review suggested CACR is effective in improving cognitive outcomes, however the review 
did not cover functional outcomes or review methodological quality.  This paper addresses 
these gaps in the literature by systematically reviewing randomised controlled trials of 
CACR that include a functional outcome measure, focusing on methodological quality and 
efficacy in improving functioning. 
 
Method: Electronic databases (Medline; PsychINFO; Embase) were searched for articles on 
schizophrenia, and both computer and cognitive remediation terms.  Cohen’s d was used to 
evaluate efficacy and an adapted version of the SIGN-50 quality assessment tool was used 
to assess methodological quality. 
 
Results: 511 papers were identified, with 22 articles covering 16 studies remaining after 
exclusion criteria.  A range of significant methodological weaknesses were found and 
almost 50% of effect sizes were small or negligible.  Methodologically stronger studies 
appeared to return smaller or negligible effect sizes.  Despite these issues, some evidence 
was found to support the suggestion that CACR may improve functional outcomes when 
delivered in conjunction with an intervention targeting the development of functional skills.   
 
Conclusions: There is little evidence to support the use of CACR as a stand-alone 




CACR when delivered in conjunction with interventions targeting the skills underpinning 
real-world functioning.   
 
Highlights: 
 A range of significant methodological weaknesses were found  
 Almost 50% of effect sizes were small or negligible 
 Methodologically stronger studies appeared to return smaller or negligible effect 
sizes 
 CACR may improve functional outcomes when delivered in conjunction with an 
intervention targeting the development of functional skills.   
 





Cognitive impairment has been referred to as a “core feature” of schizophrenia 
(Minzenberg & Carter, 2012).  Up to 90% of those diagnosed are thought to have clinically 
significant deficits in at least one domain of cognitive functioning (Palmer et al., 1997), with 
deficits persisting regardless of the presence or absence of other symptoms of 
schizophrenia (Nieuwenstein et al., 2001). 
 
Schizophrenia has also been associated with significant and disabling impairments across a 
range of functional domains, including interpersonal and occupational functioning, daily 
living skills, and the ability to benefit from intervention programmes (Green et al., 2000) .  
The most robust predictor of functional impairments has been identified as cognitive 
deficits (Green et al., 2000), which appear to have more influence on functional difficulties 
than positive or negative symptoms (Kurtz, et al., 2005). 
 
Studies suggest that the relationship between cognitive functioning and real-world 
outcomes is mediated by ‘functional capacity’ (Harvey & Strassing, 2012).  Functional 
capacity is a construct encompassing the skills necessary to perform the acts associated 
with day-to-day functioning (Harvey & Strassing, 2012) and may be as predictive of real-
world outcomes as cognitive functioning (Bowie et al., 2008).  There appears to be a 
significant overlap between functional capacity and cognitive functioning (Leifker, et al., 
2011), which suggests that the successful acquisition of functional skills is likely to be 
influenced by cognitive ability. 
 
Cognitive Remediation 
The recognition of the link between cognitive deficits and functional impairments in people 
diagnosed with schizophrenia has led to the development of cognitive remediation (CR), a 
group of psychological interventions “targeting cognitive deficit (attention, memory, 
executive function, social cognition or meta cognition) using scientific principles of learning 
with the ultimate goal of improving functional outcomes” (McGurk et al., 2013).   CR often 
involves repeating numerous trials of tasks designed to challenge particular areas of 
cognitive processing, and can also involve developing compensatory strategies to bypass 
the effects of cognitive dysfunction (Medalia & Choi, 2009).  Many CR interventions are 




range of benefits over pencil-and-paper approaches, including the automatic adjustment of 
difficulty in response to performance and the reduction in costs due to fewer hours of 
therapist involvement (Grynszpan et al., 2011). 
 
Effectiveness of Cognitive Remediation 
Two relatively recent meta-analyses have looked at the efficacy of CR.  The first, by Wykes 
et al. (2011) encompassed randomised controlled trials (RCTs) of all forms of CR and found 
a moderate effect on neuropsychological functioning (Cohen’s d effect size; ES=0.45) and a 
moderate effect on psychosocial functioning (ES=0.42).  The effect sizes for functional 
outcomes were larger when CR was delivered in conjunction with an intervention 
facilitating the generalisation of cognitive gains to daily functioning (Wykes et al., 2011).  
Concurrent functional interventions of this type have been defined as additional treatment 
components that “teach compensatory strategies and/or explicitly link cognitive gains to 
functional skills and real-world situations” (Medalia and Saperstein, 2013). 
 
The second meta-analysis focused specifically on CACR (Grynszpan et al., 2011).  Although a 
moderate effect was found on neuropsychological functioning (ES=0.38), too few studies 
employed an appropriate functional outcome measure for this to be included in analyses 
(Grynszpan et al., 2011).  The frequent omission of functional outcome measures in CR 
studies has been acknowledged as a significant weakness in the evidence base (Medalia & 
Saperstein, 2013), however since the publication of Grynszpan et al. (2011) a growing 
number of RCTs have been published with functional outcomes as a co-primary measure.  
Steps have also been taken to identify the best available measures of real-world functioning 
(the 'VALERO' study; Leifker et al., 2011) and functional capacity (MATRICS-VIM; Green et 
al., 2011) to encourage a consistent approach to measuring functioning and facilitate 
comparisons between studies. 
 
Although the evidence for CACR appears to be promising, significant concerns have been 
raised about the methodological quality of CR research, leading to recommendations that 
better quality studies are required before CR can be adopted in clinical practice (NICE, 
2009).  Advocates for CR have dismissed concerns about methodological weaknesses, with 
Wykes et al. (2011) pointing out that methodological quality did not influence effect sizes in 




efficacy studies and begin looking at implementation research.  However, it should be 
noted that the method used by Wykes et al. (2011) to explore the relationship between 
methodological quality and efficacy in meta-analyses has been challenged (Herbison, 2006). 
 
 
Rationale for the Review 
The literature suggests that CACR is associated with improvements in neuropsychological 
functioning and potentially offers a range of benefits over non-computer based CR 
approaches (Grynszpan et al., 2011).  However, a number of gaps remain in the literature, 
including a review of the efficacy of CACR in improving functional outcomes and a review of 
the methodological quality of CACR studies, both of which were omitted in the meta-
analysis by Grynszpan et al. (2011). 
 
Objectives 
This study aimed to evaluate the evidence for the effectiveness of CACR in improving 
functional outcomes for people diagnosed with schizophrenia.  It also aimed to evaluate the 
methodological rigour of studies in this area.   
 
To achieve this, a review was carried out of randomised controlled trails that assessed the 
efficacy of CACR in improving functional outcomes in individuals with a diagnosis of 
schizophrenia or schizoaffective disorder, compared to treatment as usual; a waiting list-







The review followed the processes outlined by the Centre for Reviews and Dissemination 
(2009) and was guided by The PRISMA Statement for Reporting Systematic Reviews and 
Meta-Analyses of Studies That Evaluate Health Care Interventions (Liberati et al., 2009). 
 
Eligibility of Studies 
Studies were evaluated against the following criteria: 
Types of publications: Studies were included if they were published in a peer reviewed, 
English language journal.  Unpublished dissertations and conference abstracts were 
excluded. 
Types of Studies: Studies were included if they were RCTs that employed a parallel control 
condition, including passive control conditions (treatment as usual, TAU; waiting list 
controls) or active control conditions that did not explicitly aim to improve cognitive 
functioning (e.g. a computer games control condition).  Studies were also required to state 
that allocation to treatment and control conditions was randomised, with the 
appropriateness of the randomisation method forming part of the quality review.   
Types of Participants: Participants could be of any age, with a diagnosis of schizophrenia or 
schizoaffective disorder. 
Types of Intervention: Studies were required to have a treatment condition that used 
software-based cognitive training delivered via a computer, which aims to remediate 
cognitive deficits.  Studies were included if the treatment condition involved CACR alone or 
if it involved a non-computer based element (e.g. guidance from a therapist; a concurrent 
group). 
Types of Outcome Measures: Studies were required to use one or more validated rating 







Identification of Studies 
Studies were initially identified by searching the electronic databases Medline, PsychINFO 
and Embase.  Searches were conducted on 20th October 2013 with no date restrictions 
imposed.  The search involved the same terms used by Grynszpan et al. (2011) (“computer” 
or “computerized”, “cognitive”, “rehabilitation” or “remediation” or “training”, and 
“schizophrenia”).  Duplicate studies were removed by the search engine during the search 
process. 
 
The list of titles and abstracts produced by the above process were then reviewed for 
eligibility.  This primarily involved applying the ‘Types of publications’ criteria outlined 
above, however studies were also removed if they unambiguously breached other criteria 
(e.g. a clear indication that the study used a non-RCT design, such as a case study 
approach).  Duplicate papers that were missed by the search engine were also removed.  
Full-text versions of the remaining studies were then obtained and reviewed against all of 
the eligibility criteria.   
 
The reference lists of eligible studies were then searched, along with the contents of the 
journals containing the eligible studies.  Full-text versions of any studies making reference 
to cognitive remediation were then reviewed and any meeting the eligibility criteria above 
were included in the review. 
 
Data Extraction 
From all papers involved in each individual study, the following was extracted: 
1. Methodological characteristics of the study (research question; method of 
randomisation; method of concealment of randomisation; extent of blinding; single centre 
or multi-centre) and the type of outcome measure used (including pre and post treatment 




2. Demographic characteristics of participants (including age, gender, education level), the 
study inclusion and exclusion criteria, the setting participants were recruited from (i.e. 
inpatient or outpatient) and baseline imbalances between treatment and control groups. 
3. Treatment characteristics (a description of the intervention; the frequency of treatment 
sessions; the duration of treatment) and characteristics of the control condition. 
4. Attrition rates. 
A copy of the data extraction form can be found in Appendix 1.2. 
 
Quality Assessment 
To evaluate the studies included in the review, an adapted version of the 10-item quality 
assessment tool developed by The Scottish Intercollegiate Guidelines Network for 
randomised controlled trials was used (Scottish Intercollegiate Guidelines Network, 2008). 
 
Adaptations to the SIGN assessment tool 
Previous research has indicated that there is likely to be a delay between improvements to 
cognitive functioning and the generalisation of these gains to real-world functioning (Green 
et al., 2004) which highlights the importance of ensuring that adequate follow-up 
assessments are included in CACR studies to capture any change in functional outcomes.  It 
has also been suggested that many CR studies fail to include an adequate control group 
(Boot et al., 2013).  As a result, these two factors were included alongside the original 10 
items from the SIGN assessment tool. 
 
Operationalising the assessment tool 
The 12 quality criteria were rated as ‘well covered = 2, adequately addressed = 1, poorly 
addressed/addressed/not reported/not applicable = 0.  Lower scores on the quality tool 
either represented an increased risk of bias resulting from the item, or a lack of information 





Scores were totalled across the quality criteria and an overall percentage score given.  Full 
details of the scoring system can be found in Appendix 1.3.  Where relevant, the scoring of 
quality criteria focused on aspects of the study specific to functional outcomes (e.g. 
blinding was scored in relation to the assessment of functional outcomes, regardless of 
whether assessments of neuropsychological or symptom outcomes were blinded). 
 
Scoring the quality assessment tool 
All studies were rated by the author, while 50% were also rated by an individual 
independent of the study.  Inter-rater agreement was ‘good’ (Kappa=0.70; Cohen, 1960) 
according to standards set out by Landis and Koch (1977) .  Differences between raters 
were discussed until a consensus was reached, with scores amended accordingly. 
 
It should be noted that one item from the quality criteria, ‘Results Comparable Across 
Sites’, is only applicable to multi-centre studies.  As such, this item was omitted for single-
centre studies, with the overall score adjusted accordingly. 
 
Data Analysis 
Effect sizes were calculated using Cohen’s d (Cohen, 1992), based on the means and 
standard deviations published in the paper for each functional outcome measure or the 
subscale of each measure at each time point (i.e. post-treatment, follow-up).  For the 
calculation of effect sizes, the control group was considered to be the treatment as usual 
group, the waiting list control group, a computer games control condition, or any other 








The CONSORT diagram in Figure 1 provides an account of the search process and Table 1 
provides details of each study included in the review.  A list of papers that were subject to a 
full text review but were excluded from the study can be found in Appendix 1.4, along with 
reasons for their exclusion. 
 
Study characteristics 
22 different reports of 16 studies, reporting data on 1061 participants, met the inclusion 
criteria.  Papers were published between the years 2004 and 2013.  Eight studies recruited 
from outpatient settings, three from inpatient settings, two from both, while three did not 
specify.  Studies were carried out in eight different countries.  The average sample size was 
approximately 66 (mean=66.31, SD=23.47). 
 
Participant characteristics 
Participants were in their early 40s (n=16, mean age=40.59, SD=12.19), predominately male 




Across the studies reviewed, 17 different functional outcome measures were used.  The 
modal number of measures used in each study was one, however three studies employed 
three different functional outcome measures.  Two studies combined multiple outcomes 
into a single composite measure.  A description of the outcomes measures used can be 
found in Appendix 1.5. 
 
 
Figure 1: CONSORT diagram 
 
 
 Articles identified through manual 
searches of reference lists and journals 
n= 76 
Articles identified through database 
searches n= 435 
Duplicate articles removed n = 162 
Titles and abstracts screened 
 n = 349 
Articles excluded   
 n = 222 
Full text articles assessed for eligibility 
n= 127 
Full text articles 
excluded with reasons n 
= 105 




Table 1: Summary of included studies 





age in years; 









Treatment Delivered  






















Computer Assisted Cognitive 
Remediation for Schizophrenia; 
n=34 
None 15 weeks; 
3 x 1 hour; 
36 sessions (target) 















Thinking Skills for Work 
Programme (incorporates 
Cogpack, PSSCogRehab and 
Scientific Brain Training) 
n=36 
None 12 weeks; 
2 hours per week; 
24 hours (target) 



















Posit Science Brain Fitness 
Auditory Training; 
n=22 
None 10-20 weeks; 
5 x 1 hour; 
50 or 100 hours (target); 





















1 x 1 hour; 


































3 x 1 hour; 




















1. CogRehab plus d-serine 
n=24 
2. CogRehab plus placebo d-
serine 
n=27 
None 12 weeks; 
5 hours over 2-3 days; 




































None 6 months; 

























None 24 weeks; 
2 x 45 mins; 
























5 hours per week; 





































Gexy and copy programmes, 
and Bracy Soft Tools; 
n=38 
None 6 months; 















Educational Approach to 
Remediation; 
n=22 
None 10-15 weeks; 
2 x 1 hour; 
















None 3 months; 
1 or 2 x 1 hour; 






















Computer Drill Training 
Programme; 
n=14 
None 4-6 weeks; 
















None 7 weeks; 
































1 year SA=0.37 (0.47) 
*Where study data is across multiple papers, the earliest published paper is used to identify the study in the body of the text; **Abbreviations: 
AC=Adaptive composite;  AD=The Interview for the Assessment of Disability;  EAS=Social Autonomy Scale; GAF=Global Assessment of Functioning; 
H0NOS=Health of the Nation Outcome Scale; LSP=Life Skills Profile; MASC=Maryland Assessment of Social Competence; PSP=Personal and Social 
Performance Scale; QLS=Quality of life scale; SA=Social Adjustment; SLOF=Specific Levels of Functioning Scale; SOFAS=Social and Occupational 
Functioning Scale; SQoL=Schizophrenia Quality of Life; SSA=Social Skills Performance Assessment; UPSA=University of California San Diego 
Performance-Based Skills Assessment Battery; WBI=Work-Behaviour Inventory; WHOQOL-Bref=World Health Organization Quality of Life-BREF; 




11 different CACR programmes were used.  The most frequently used CACR interventions 
were Rehacom and Cogpack which were each used by three studies.  Some studies used 
elements from multiple CACR interventions (Bowie et al., 2012; Garrido et al., 2013).   
 
Variability in the reporting of the total number of hours of treatment delivered, as well as 
the frequency of sessions, precludes the calculation of averages across studies, however 
details of these aspects of treatment can be found in Table 1 for each study.  
 
Methodological Quality 
Table 2 provides a breakdown of the quality ratings for the 16 studies included in the 
review.  Significant areas of methodological quality are discussed below. 
 
Attrition 
Scores for attrition rates in Table 2 reflect both the proportion who dropped out during 
treatment, as well as approximate equivalence in attrition between control and 
experimental groups.  Two studies failed to report attrition rates (Hodge et al., 2010;d’ 
Amato et al., 2011), while three others scored ‘1’ or ‘0’ due to high overall attrition rates 
(Eack et al., 2009; Fisher et al., 2009; Byrne et al., 2013).  The relatively high attrition rate in 
the Eack et al. (2009) study perhaps reflects that the intervention took place over a longer 
period than in other studies (two years).  Byrne et al. (2013) had the highest level of 
attrition of any of the studies and also had large differences in attrition between groups.  It 
should be noted that this was one of only two studies to solely recruit inpatients and was 
also the only study to give comprehensive details of the reasons for attrition.  Two other 
groups scored lower due to differences in attrition between groups (D’Souza et al., 2012; 
Garrido et al., 2013), which may in part reflect the qualitative differences between the 






While no studies appeared to use an inappropriate method of randomisation, the majority 
simply stated that participants had been randomised into groups, with only six providing a 
clear enough description to judge the appropriateness of the procedure.  Similarly, efforts 
to conceal the randomisation process from researchers were only mentioned in a minority 
of studies.  None of these gave a clear description of the process used and all were 
therefore scored as ‘1’. 
 
Outcomes measures 
All measures were validated rating scales as this was an inclusion criteria for the study, 
however those scoring ‘1’ represents the fact that these were not validated for use with a 
schizophrenia population.  Nine studies used measures recommended either by the 
VALERO (Leifker et al., 2011) or the MATRICS-VIM studies (Green et al., 2011) (UPSA, QLS, 
LSP, SLOF). 
 
Control group and blinding 
Only four studies scored ‘2’ for using a computer games control condition.  All four 
attempted to match other aspects of the control condition to those of the experimental 
group, such as the frequency of sessions and contact with therapists.  One of the studies 
using a computer games control took steps to ensure that both assessors and participants 
were blind to the treatment condition (Dickinson et al., 2010); two blinded assessors only 
(Fisher et al., 2009; Keefe et al., 2012); while one ensured only participants were blinded 
(Cavallaro et al., 2009). 
 
 
Table 2: Summary of quality ratings 
               



























et al., 2010 
2 2 2 2 0 2 0 1 
 
2 2 0 2 17 70.83% 
Bowie et 
al., 2012 
2 2 2 1 0 0 2 1 
 
1 2 1 2 16 66.67% 
Fisher et 
al., 2009 
1 2 1 1 1 1 1 2 
 
2 2 0 2 16 66.67% 
Eack et al., 
2009 
1 2 2 2 0 0 1 2 
 
1 2 2 0 15 62.50% 
Cavallaro 
et al., 2009  
2 2 1 1 0 1 1 2 2 2 0 0 14 58.33% 
D’Souza et 
al., 2012 
1 2 1 2 0 1 1 1 
 
1 1 0 2 13 54.17% 
Bucci et 
al., 2013 
2 2 0 1 1 1 0 2 
 
1 2 0 0 12 50.00% 
Vita et al., 
2011 
2 2 1 1 1 0 0 0 
 
1 2 2 0 12 50.00% 
Keefe et 
al., 2012 




et al., 2010 
2 2 2 1 1 1 0 0 
 
1 1 0 0 11 45.83% 
Garrido et 
al., 2013 
1 0 2 2 1 1 0 0 
 
1 2 0 Omit 10 45.45% 
Hodge et 
al., 2010 
0 2 2 2 1 0 0 1 
 
0 2 0 0 10 41.67 % 




0 2 0 Omit 9 40.91% 
Byrne et 
al., 2013 




et al., 2011 
0 2 2 1 0 1 0 0 
 
0 2 0 0 8 33.33% 
Hogarty et 
al., 2004 
2 0 0 1 0 0 0 2 1 2 0 0 8 33.33% 
Key: 2=Well covered; 1=Adequately addressed; 0=Poorly addressed/not addressed/not reported; Omit=item not applicable 
 
 
Table 1 includes a description of the control conditions for the remaining studies.  Eight 
studies scored ‘1’ and used a variety of active control conditions, such watching videos.  The 
extent to which these active conditions control for non-specific aspects of treatment will 
vary, however it should be noted that a number attempted to match some aspects of the 
experimental condition, such as therapist contact.   
 
Other treatment 
Six papers attempted to account for other treatments that could create imbalances 
between groups.  Five of these papers scored a ‘1’ as the description only accounted for 
changes to medication regimes during treatment.  Bowie et al. (2012) was the only paper to 
score ‘2’ due to giving a clear account of ongoing treatment and assurances that this 
excluded anything that would be likely to affect cognitive or functional outcomes. 
 
Follow-up 
Almost half the studies failed to include any follow-up.  Of those that did, only five scored 
‘2’ for following-up participants at 6 months or beyond.  Only one paper included follow-




Only three studies included an ITTA, with one only scoring ‘1’ for failing to explain the 
procedure used to address missing data (Bowie et al., 2012).  One paper used a “modified 
ITTA” (Dickinson et al., 2010).  Although this may have retained some of the methodological 
benefits of an ITTA, it was scored as a ‘0’ for violating the ITTA principles by failing include 











The majority of studies were classed as multi-centre as participants were recruited across 
multiple locations, however it was often not reported if treatment and assessments also 
took place across multiple locations.  Only five studies accounted for potential differences 
between sites in their analyses. 
 
Efficacy 
The overall effect of CACR in relation to functional outcomes is covered below, before 
efficacy is discussed in relation to a range of methodological issues. 
 
Overall 
Based on conventions for the categorisation of effect sizes (Cohen, 1992), 92.31% of studies 
reporting post-treatment data had at least one outcome measure demonstrating a small 
effect size (d≥0.2) post-treatment, 53.85% had at least 1 medium effect size (d≥0.5), and 
15.38% had at least 1 large effect size (d≥0.8).  Looking at each of the post-treatment effect 
sizes in Table 1, 22.22% are small, 18.53% are medium, and 11.11% are large.  Almost half 
of the calculated effect sizes (48.15%) do not meet the criteria to be classed as “small”. 
 
Two studies did not publish post-treatment means and standard deviations for functional 
measures and therefore no effect size was calculated.  One study (Fisher et al., 2009) only 
provided means and standard deviations at the follow-up stage, therefore there is no post-
treatment effect size. 
 
Control group and blinding 
For well controlled studies (i.e. those scoring ‘2’), post-treatment effect sizes ranged from -








(Dickinson et al., 2010), all effect sizes failed to reach the threshold to be considered 
‘small’.  Despite this, two well-controlled studies (Dickinson et al., 2010; Cavallaro et al., 
2009) found increased effect sizes at follow-up, with Cavallaro et al. (2009) finding a 
progressive increase in effect sizes at each follow-up stage.  This may indicate that it takes 
time for the cognitive benefits of treatment to generalise to functional outcomes, however 




In total, five studies reassessed participants six months or longer after treatment ended and 
found small to medium effects at the follow-up stage.  It should be noted that two of these 
studies (Hogarty et al., 2004; and Bucci et al., 2013) were among the lowest rated in terms 
of overall quality.   However, three were among the highest rated overall for quality (Fisher 
et al., 2009; Cavallaro et al., 2009; Eack et al., 2009).  The two that found a medium effect 
size at follow-up were also the studies that involved a concurrent intervention targeting 
functional outcomes (Cavallaro et al., 2009; Eack et al., 2009), which may help to account 
for the durability of these effects. 
 
Concurrent functional intervention 
Five studies included a functional intervention alongside CACR (Eack et al., 2009; Cavallaro 
et al., 2009; Keefe et al., 2012; Galderisi et al., 2010; Hogarty et al., 2004).  Post-treatment 
effect sizes ranged from -0.15 to 1.02, and all studies found at least a small effect post-
treatment, with the exception of Keefe et al. (2012).  The largest effect size was from Eack 
et al. (2009), whose functional intervention appears to be the most comprehensive, lasting 
2 years.  These results lend some tentative weight to the idea that the generalisation of 
cognitive improvements to functional outcomes is best achieved when CACR is delivered 
with a functional intervention.  It was not possible to calculate ES for Bowie et al. (2012), 
however their results provide additional support to this argument.  The study involved 








the functional intervention.  CACR was only associated with improved functioning when 
delivered in combination with the functional intervention, which also outperformed the 
functional intervention on its own (Bowie et al., 2012). 
 
Multi-centre 
The three single centre studies mostly returned medium to large effect sizes (Garrido et al., 
2013; Lee, 2013; Byrne et al., 2013), reflecting previous research that suggests single-centre 
approaches return higher effects than multi-centre studies (Kahan, 2014).  However it 




Of the recommended outcome measures used within the studies reviewed, effect sizes 
were available for both the UPSA and QLS (see Table 1).  No studies using the UPSA found 
even a small post-treatment effect, however none employed a concurrent functional 
intervention.  With regards to the QLS, Garrido et al. (2013) and Cavallaro et al. (2009) 
found medium effect sizes at post-treatment or follow-up with Bucci et al. (2013) also 













This systematic review aimed to look at the methodological quality and efficacy of CACR in 
improving functional outcomes.  A range of significant methodological weaknesses were 
identified, while the effect sizes were mostly small or negligible.  Although it was only 
possible to take a descriptive look at the relationship between methodology and efficacy, it 
would appear that methodologically stronger studies tended to return small or negligible 
effect sizes.  Despite these issues, some evidence was found to support the suggestion that 
CACR may improve functional outcomes when delivered in conjunction with an 
intervention targeting the generalisation of cognitive gains to day-to-day functioning. 
 
Do the methodological limitations matter? 
Past concerns about the methodological quality of CR studies led to the intervention not 
being recommended in clinical guidelines (NICE, 2009).  Similarly, the meta-analysis of CR 
by (Wykes et al., 2011) included a measure of methodological quality and found that less 
than a third of studies reached the threshold to be considered “adequate” (Wykes, et al. 
2007).  Despite this, Wykes et al. (2011) did not find any relationship between scores on the 
quality measure and effect sizes, leading them to conclude that methodological limitations 
do not inflate effect sizes.  As an explanation, they suggest that inadequate blinding 
procedures are less concerning for CR RCTs in comparison to other psychological therapies 
such as CBT for psychosis, as cognitive outcome measures are less prone to bias compared 
to symptom outcome measures. 
 
The dismissal of methodological problems in CR by Wykes et al. (2011) can be challenged 
on a number of counts.  Cognitive measures may be designed to reduce bias, however an 
element of clinical judgement is still involved and these assessments may be more prone to 
bias than Wykes et al. (2011) imply.  Regardless, many measures of functioning rely heavily 
on clinical judgement, leaving blinding as an important design feature of future RCTs of 








quality on outcomes has been criticised, principally because such measures can omit 
significant aspects of methodology, and different quality measures often give different 
results (Herbison et al., 2006).  As a result, the methodological limitations of CACR and CR 
studies cannot be so easily dismissed. 
 
Efficacy of CACR 
The lack of functional improvements found in this study, taken in conjunction with 
Grynszpan et al. (2011)’s findings of improvements to cognitive outcomes following CACR, 
suggest that while cognitive deficits may predict deficits in functioning, cognitive 
improvements do not automatically lead to improvements in functioning.  It seems likely 
that the generalisation of cognitive improvements to day-to-day functioning requires the 
mediation of a functional intervention that facilitates practicing the underlying skills.  This 
would reflect the findings of this review, as well as those of the meta-analysis by (Wykes et 
al., 2011), that the addition of a functional intervention alongside CACR appears to be 
associated with functional improvements.  The study by Bowie et al., (2012) would further 
support this idea, with their finding that the benefits of CACR generalised to functional 
outcomes when paired with a functional skills training.  This suggests that CACR should be 
reconceptualised as a ‘booster’ for functional interventions, rather than a ‘stand-alone’ 
therapy. 
 
Recommendations for future research 
Given the limitations found in the research covered in this review, little value can be added 
by further efficacy studies that fail to use rigorous methodological approaches.  The design 
of future RCTs should pay particular attention to the related issues of blinding and control 
groups.  In comparison to other psychological interventions, the nature of CACR creates 
greater scope for the development of control groups that closely resemble intervention 
conditions (Boot et al., 2013), which in turn facilitates the possibility of blinding both 









The review would also suggest that there is limited benefit to further studies of CACR as a 
stand-alone intervention.  Although the findings suggest that a concurrent intervention is 
required to generalise cognitive gains, there remain few methodologically sound studies to 
support this.  Further research is required, and may benefit from broadly following the 
approach of Bowie et al. (2012) to explore the relative contributions of cognitive and 
functional treatment elements.  Also, participants should be followed up at least 6 months 
after the end of therapy, given the potential time-lag between therapy and skill acquisition 
(Green et al, 2004). 
 
More broadly, future meta-analyses of the efficacy of CACR should explore the effect of 
methodological weaknesses on effect sizes, otherwise doubts will remain over the 
effectiveness of CACR.  It will be important that this involves a different method to that 
used by Wykes et al. (2011). 
 
Recommendations for clinical practice 
The results of this review would indicate that there is little evidence to support the 
implementation of CACR as a stand-alone intervention to improve functional outcomes.  In 
addition, there remains only preliminary evidence that CACR combined with a functional 
skills intervention has any impact on functional capacity of real-world functioning.  As such, 
further research is required before CACR can be recommended for clinical practice, if the 
goal of treatment is to improve functioning. 
 
Strengths of the Review 
The review fills a significant gap in the literature by systematically reviewing the evidence 
base for the efficacy of CACR in addressing functional deficits.  It also provides an 
evaluation of CACR methodology that is not present in the published literature.  The quality 
evaluations demonstrated good inter-rater reliability.  The review also provides a broad 
coverage of the literature by implementing few limitations on outcome measures, CACR 









Weaknesses of the Review 
The review only covers English language publications due to resource limitations restricting 
the ability to translate papers.  Quality ratings have been made on the basis of trial reports 
and authors have not been contacted; therefore some of the ratings may reflect reporting 
omissions rather than methodological limitations.  The quantitative approach used to 
assess the quality of studies has been criticised (Herbison et al., 2006) and it is possible that 
this gives an inaccurate assessment of relative methodological strength.  The criteria used 
to rate specific aspects of methodology may inadvertently mask relative strengths or 
weaknesses (e.g. giving the same rating to “modified” ITTA as to those that used no ITTA). 
 
The review aimed to address a gap in the literature, with search terms and eligibility criteria 
chosen to provide continuity between this review and the meta-analysis by Grynszpan et al. 
(2011).  As a consequence, schizoaffective disorder was not included as a search term 
despite studies being included if participants had this diagnosis.  This mismatch between 
search terms and inclusion criteria creates the possibility that studies meeting eligibility 
criteria may not have been picked up in the original search. 
 
Conclusion 
Past criticisms of the methodological quality of CR interventions continue to be valid in 
relation to the subset of CACR studies that include a functional outcome measure.  
Although there is little high quality evidence to indicate stand-alone CACR is effective in 
improving functioning, there is some promise that it may act as a  ‘booster’ treatment for 
interventions that aim to develop the skills underpinning real-world functioning.  
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Appendix 1.2 – Data Extraction Form 
Data extraction form 
Study ID (surname of first author from the first 
full report of study, and year first full report of 
study was published e.g. Smith 2001) 
 
Report ID(s)  
Notes       
General Information 
Date form completed 
(dd/mm/yyyy) 
      
Reference citation(s)       





(Insert inclusion criteria for each 
characteristic as defined in the Protocol) 
Eligibility criteria met?   
Yes No Unclear 
Type of study Randomised Controlled Trial 
   
      
      
Participants 
 
Over 18              
Diagnosis schizophrenia/schizoaffective 
disorder (in both treatment group and 
experimental group) 




Computer based CRT   
 
   






CACR vs TAU    
CACR vs active control   
 
Not-eligible: 
   








group) CACR vs CACR    





Standardised functional outcome 
measures used at pre and post treatment 
stage 
   
      
 
INCLUDE   
 
 





      
Notes:         
 
 








Characteristics of included studies 
Methods 






Design (note any 
issues with 
equivalence of arms)  
Single centre   












NR   Adequate  (Please specify): 






Single    
Double   
Triple   
Not possible  
No blinding  











Include comparative information for each intervention or comparison 
group if available 
Population description 
(from which study 
participants are drawn) 
 
Setting (including 
location and social 
context) 
        
Inpatient Outpatient Unclear  NR 
 
Inclusion criteria   
Exclusion criteria  
Total no. randomised  
(or total pop. at start of 
study for NRCTs) 
 
Baseline imbalances  
Number of withdrawals 
and exclusions 
(if not provided below 
by outcome) 
 
Age   
Sex  
Race/Ethnicity  
Socio-economic status  










Copy and paste table for each intervention and comparison group  
Treatment Group 
 Description as stated in report/paper 
 
Group (from paper)  
No. randomised to group  
Age   
Sex (%) Male: 
Female: 
Race/Ethnicity (%)  
Socio-economic status (%)  
Education  
Description of intervention 
(include sufficient detail for 
replication, e.g. content, 
dose, components) 
 
Duration of treatment 
period 
 
Timing (e.g. frequency, 
duration of each episode) 
 
Delivery (e.g. computer 
only?  Therapist involved?  













 Description as stated in report/paper 
 
Group (from paper)  
No. randomised to group  
Age   
Sex (%) Male: 
Female: 
Race/Ethnicity (%)  
Socio-economic status (%)  
Education  
Description of intervention 
(include sufficient detail for 
replication, e.g. content, 
dose, components) 
 
Duration of treatment 
period 
 
Timing (e.g. frequency, 
duration of each episode) 
 
Delivery (e.g. computer 
only?  Therapist involved?  
















Group (from paper)  
No. randomised to group  
Age   
Sex (%) Male: 
Female: 
Race/Ethnicity (%)  
Socio-economic status (%)  
Education  
Description of intervention 
(include sufficient detail for 
replication, e.g. content, 
dose, components) 
 
Duration of treatment 
period 
 
Timing (e.g. frequency, 
duration of each episode) 
 
Delivery (e.g. computer 
only?  Therapist involved?  












Copy and paste table for each outcome – i.e. each assessment of neuro functioning, functional 
outcomes, symptoms and any others assessed. 
Outcome 1 
 Description as stated in report/paper 
 
Outcome name (as used 
in paper) 
      
Assessment tool (Name)  
No. of patients evaluated 
for this outcome 
All randomised  
Unclear   
Fewer   ___% 
Domain         




   
Yes No Unclear 
 
Is outcome/tool 
validated for this 
population? 
   




fy whether from start or 
end of intervention) 
      
 
Outcome 2 









Outcome name (as used 
in paper) 
      
Assessment tool (Name)  
No. of patients evaluated 
for this outcome 
All randomised  
Unclear   
Fewer   ___% 
Domain         




   
Yes No Unclear 
 
Is outcome/tool 
validated for this 
population? 
   




fy whether from start or 
end of intervention) 
      
 
Outcome 3 
 Description as stated in report/paper 
 
Outcome name (as used 
in paper) 
      
Assessment tool (Name)  
No. of patients evaluated 
for this outcome 
All randomised  
Unclear   








Domain         




   
Yes No Unclear 
 
Is outcome/tool 
validated for this 
population? 
   




fy whether from start or 
end of intervention) 








Data and Analysis 
Copy and paste the appropriate table for each outcome, including additional tables for each time 
point and subgroup as required. 
Outcome 1 
 Description as stated in report/paper 
 
Outcome        
Time point 
(specify from start or 
end of intervention) 
Pre-treatment 
Results Intervention Comparison 











                                    
Any other results 
reported (e.g. mean 
difference, CI, P value) 
      
No. participants 
moved from other 
group 
            
Reasons moved             
Time point 
(specify from start or 













Statistically significant change 
Yes  No     
Enter p-value: 
 
If not sig. was it due to: 
Evidence of absence of 
treatment effect (i.e. clearly 
defined based on primary 
outcomes in the trial) 
No evidence for absence 
of treatment effect (i.e. 
inconclusive, or low powered 
study)(i.e. not clearly defined 
or based on primary 
outcomes from the study) 
Unclear 
Comparison 
Statistically significant change 
Yes  No     
Enter p-value: 
 
If not sig. was it due to: 
Evidence of absence of treatment effect 
(i.e. clearly defined based on primary outcomes 
in the trial) 
No evidence for absence of treatment 
effect (i.e. inconclusive, or low powered 
study)(i.e. not clearly defined or based on 
primary outcomes from the study) 
Unclear 
Results Intervention Comparison 











                                    
Any other results 
reported (e.g. mean 
difference, CI, P value) 
      
No. missing 
participants 
            
Reasons missing             
No. participants 
moved from other 
group 
            
Reasons moved             
Time point 
(specify from start or 













Statistically significant change 
Yes  No     
Enter p-value: 
 
If not sig. was it due to: 
Evidence of absence of 
treatment effect (i.e. clearly 
defined based on primary 
outcomes in the trial) 
No evidence for absence 
of treatment effect (i.e. 
inconclusive, or low powered 
study)(i.e. not clearly defined 
or based on primary 
outcomes from the study) 
Unclear 
Comparison 
Statistically significant change 
Yes  No     
Enter p-value: 
 
If not sig. was it due to: 
Evidence of absence of treatment effect 
(i.e. clearly defined based on primary outcomes 
in the trial) 
No evidence for absence of treatment 
effect (i.e. inconclusive, or low powered 
study)(i.e. not clearly defined or based on 
primary outcomes from the study) 
Unclear 
Results Intervention Comparison 











                                    
Any other results 
reported (e.g. mean 
difference, CI, P value) 
      
No. missing 
participants 
            
Reasons missing             
No. participants 
moved from other 
group 
            










 Description as stated in report/paper 
 
Outcome        
Time point 
(specify from start or 
end of intervention) 
Pre-treatment 
Results Intervention Comparison 











                                    
Any other results 
reported (e.g. mean 
difference, CI, P value) 
      
No. participants 
moved from other 
group 
            
Reasons moved             
Time point 
(specify from start or 













Statistically significant change 
Yes  No     
Enter p-value: 
 
If not sig. was it due to: 
Evidence of absence of 
treatment effect (i.e. clearly 
defined based on primary 
outcomes in the trial) 
No evidence for absence 
of treatment effect (i.e. 
inconclusive, or low powered 
study)(i.e. not clearly defined 
or based on primary 
outcomes from the study) 
Unclear 
Comparison 
Statistically significant change 
Yes  No     
Enter p-value: 
 
If not sig. was it due to: 
Evidence of absence of treatment effect 
(i.e. clearly defined based on primary outcomes 
in the trial) 
No evidence for absence of treatment 
effect (i.e. inconclusive, or low powered 
study)(i.e. not clearly defined or based on 
primary outcomes from the study) 
Unclear 
Results Intervention Comparison 











                                    
Any other results 
reported (e.g. mean 
difference, CI, P value) 
      
No. missing 
participants 
            
Reasons missing             
No. participants 
moved from other 
group 
            
Reasons moved             
Time point 
(specify from start or 













Statistically significant change 
Yes  No     
Enter p-value: 
 
If not sig. was it due to: 
Evidence of absence of 
treatment effect (i.e. clearly 
defined based on primary 
outcomes in the trial) 
No evidence for absence 
of treatment effect (i.e. 
inconclusive, or low powered 
study)(i.e. not clearly defined 
or based on primary 
outcomes from the study) 
Unclear 
Comparison 
Statistically significant change 
Yes  No     
Enter p-value: 
 
If not sig. was it due to: 
Evidence of absence of treatment effect 
(i.e. clearly defined based on primary outcomes 
in the trial) 
No evidence for absence of treatment 
effect (i.e. inconclusive, or low powered 
study)(i.e. not clearly defined or based on 
primary outcomes from the study) 
Unclear 
Results Intervention Comparison 











                                    
Any other results 
reported (e.g. mean 
difference, CI, P value) 
      
No. missing 
participants 
            
Reasons missing             
No. participants 
moved from other 
group 
            










 Description as stated in report/paper 
 
Outcome        
Time point 
(specify from start or 
end of intervention) 
Pre-treatment 
Results Intervention Comparison 











                                    
Any other results 
reported (e.g. mean 
difference, CI, P value) 
      
No. participants 
moved from other 
group 
            
Reasons moved             
Time point 
(specify from start or 













Statistically significant change 
Yes  No     
Enter p-value: 
 
If not sig. was it due to: 
Evidence of absence of 
treatment effect (i.e. clearly 
defined based on primary 
outcomes in the trial) 
No evidence for absence 
of treatment effect (i.e. 
inconclusive, or low powered 
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or based on primary 
outcomes from the study) 
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Statistically significant change 
Yes  No     
Enter p-value: 
 
If not sig. was it due to: 
Evidence of absence of treatment effect 
(i.e. clearly defined based on primary outcomes 
in the trial) 
No evidence for absence of treatment 
effect (i.e. inconclusive, or low powered 
study)(i.e. not clearly defined or based on 
primary outcomes from the study) 
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If not sig. was it due to: 
Evidence of absence of treatment effect 
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Appendix 1.3 – Quality Assessment Tool 
Quality Assessment Tool 
AUTHOR: Martin Gallagher 
SUPERVISORS: Dr Suzanne O’Rourke, Dr Alana Davis, Prof Matthias Schwannauer 
DATE:  
ID:  
 Quality Criteria Score 
1. Sample 
1.1 Attrition rates are clearly stated and are similar for both treatment and control groups  
1.2 The treatment and control groups are similar at the start of the trial  
Total:  /4 
2. Study design 
2.1 The study addresses an appropriate and clearly focused question  
2.2 The assignment of participants to groups is randomised  
2.3 An adequate concealment method is used  
2.4 Participants and investigators are kept ‘blind’ about treatment allocation  
2.5 The only difference between groups is the treatment under consideration  
2.6 Participants are followed-up sufficiently  
2.7 The control condition involves a qualitatively similar task to the experimental condition  
Total:  /14 
3. Outcomes 
3.1 All relevant outcomes are measured in a standard, valid and reliable way  
Total:  /2 
4. Results and statistical analysis 
4.1 All the participants are analysed in the groups to which they were randomly allocated 
(often referred to as intention to treat analysis) 
 
4.2 Where the study is carried out at more than one site, results are comparable for all sites  
Total:  /4 













1.1 Attrition rates are clearly stated and are similar for both treatment and control groups 
Well covered (2) Attrition rates (between pre and post treatment stages) are 
clearly stated for both groups.  Attrition rates should be within 
10% of each other for treatment and control groups.  Attrition 
rates should be less than 20% of the total. 
 
Adequately addressed (1) Attrition rates are clearly stated for both groups.  Attrition 
rates should be within 20% of each other for treatment and 
control groups.  Attrition rates should be less than 30% of the 
total. 
 
Poorly addressed (0) Attrition rates are significantly different between groups or 
account for a significant proportion of the total. 
 
Not addressed (0)   
Not reported (0)   
Not applicable (0)   
1.2 The treatment and control groups are similar at the start of the trial 
Well covered (2) Full details of baseline characteristics are given (e.g. gender, 
age, diagnosis, years of education, cognitive functioning etc.).  
Groups are sufficiently alike at baseline or any differences are 
controlled for during the analysis. 
 
Adequately addressed (1) Reasonable details of baseline characteristics are given.  
Groups are somewhat alike. 
 
Poorly addressed (0) Limited details of baseline characteristics are given or baseline 
differences are not controlled for during the analysis. 
 
Not addressed (0)   
Not reported (0)   
Not applicable (0)   
Total section 1:  /4 
2. Study design 
2.1 The study addresses an appropriate and clearly focused question 
Well covered (2) An appropriate and clearly focused research question is 
described, with clearly stated hypotheses. 
 
Adequately addressed (1) A research question is described, however it may be lacking in 
clarity or focus and hypotheses are not clearly stated. 
 
Poorly addressed (0) The research question is unclear.  
Not addressed (0)   
Not reported (0)   
Not applicable (0)   
2.2 The assignment of participants to groups is randomised 
Well covered (2) The randomisation process is clearly described and uses an 
appropriate method.  (e.g.  
 
Adequately addressed (1) The paper states that a randomisation process was used but 
the process itself is not clearly described. 
 
Poorly addressed (0) The paper states that a randomisation process is used but the 
method is not appropriate. 
 








Not reported (0)   
Not applicable (0)   
2.3 An adequate concealment method is used 
Well covered (2) An appropriate method is used to ensure that researchers are 
unaware of the group that participants are being allocated to 
at the time of entry to the study.  The method is clearly 
described. 
 
Adequately addressed (1) Concealment appears to have been carried out, however a 
clear description is not given. 
 
Poorly addressed (0) The method of concealment is likely to be ineffective at 
ensuring researchers are unaware of the group that 
participants are being allocated to at the time of entry to the 
study. 
 
Not addressed (0)   
Not reported (0)   
Not applicable (0)   
2.4 Participants and investigators are kept ‘blind’ about treatment allocation 
Well covered (2) Both participants and those scoring/interpreting the results 
are blind to treatment condition. 
 
Adequately addressed (1) Those scoring/interpreting the results are blind to the 
treatment condition but the participants are not. 
 
Poorly addressed (0) Those scoring/interpreting the results are aware of the 
treatment condition. 
 
Not addressed (0)   
Not reported (0)   
Not applicable (0)   
2.5 The only difference between groups is the treatment under consideration 
Well covered (2) It is clear that groups were treated equally and that no 
additional treatment was given that could be a potential 
confounding factor. 
 
Adequately addressed (1) Reasonably clear that no additional treatment was given that 
could be a potential confounding factor. 
 
Poorly addressed (0) It is unclear whether any additional treatment was given that 
could be a potential confounding factor. 
 
Not addressed (0)   
Not reported (0)   
Not applicable (0)   
2.6 Participants are followed-up sufficiently 
Well covered (2) Follow-up occurs 6 months or more after post-treatment 
assessments 
 
Adequately addressed (1) Follow-up occurs 3 to 5 months after post-treatment 
assessments 
 
Poorly addressed (0) Follow up occurs less than 3 months after post-treatment 
assessments 
 
Not addressed (0)   








Not applicable (0)   
2.7 The control condition involves a qualitatively similar task to the experimental condition 
Well covered (2) The control condition involves completing a computer task  
Adequately addressed (1) An active control group is used, but does not involve a 
computer task  
 
Poorly addressed (0) The control condition contains no active element (i.e. involves 
TAU) 
 
Not addressed (0)   
Not reported (0)   
Not applicable (0)   
Total section 2:  /14  
3. Outcomes 
3.1 All relevant outcomes are measured in a standard, valid and reliable way 
Well covered (2) Standardised measures are used with well reported 
psychometric properties in this population.   
 
Adequately addressed (1) Standardised measures are used with adequate psychometric 
properties, however there is little evidence of 
reliability/validity in this population. 
 
Poorly addressed (0) Non-standardised measures are used  
Not addressed (0)   
Not reported (0)   
Not applicable (0)   
Total section 3:  /2           
4.  Results and Statistical Analysis 
4.1 All the participants are analysed in the groups to which they were randomly allocated (often 
referred to as intention to treat analysis) 
Well covered (2) An intention to treat analysis is carried out and described in 
detail, with all participants analysed in the groups to which 
they were randomly allocated 
 
Adequately addressed (1) An intention to treat analysis is carried out, however few 
details are given 
 
Poorly addressed (0) It is unclear if an intention to treat analysis is carried out or 
this was not carried out appropriately. 
 
Not addressed (0)   
Not reported (0)   
Not applicable (0)   
4.2 Where the study is carried out at more than one site, results are comparable for all sites 
Well covered (2) Detailed results from each site are given.  These are compared 
and any differences are controlled the analysis 
 
Adequately addressed (1) Limited details of the results from each site are given.  These 
are compared and any differences are controlled in the 
analysis 
 
Poorly addressed (0) No details of the results from each site are given or any 
differences are not controlled in the analysis. 
 
Not addressed (0)   








Not applicable (0)   




Appendix 1.4 – Papers excluded following the full-text review 
Reference Reason for exclusion 
An, S., Oh, B., Hyun, M., & Yoo, K. (1997). The Effect of 
Attention Training Using Computer-Aided Cognitive 
Rehabilitation Program (REHACOM) in Chronic 
Schizophrenics.  Journal of the Korean Neuropsychiatric 
Association, 36(1), 72–79. 
Non-English language 
Bark, N., Revheim, N., Huq, F., Khalderov, V., Ganz, Z. 
W., & Medalia, A. (2003). The impact of cognitive 
remediation on psychiatric symptoms of schizophrenia. 
Schizophrenia Research, 63(3), 229–235. 
No functional outcome 
measure 
Bell, M., Bryson, G., Greig, T., Corcoran, C., & Wexler, B. 
(2001). Neurocognitive enhancement therapy with 
work therapy: effects on neuropsychological test 
performance. Archives of General Psychiatry, 58, 763–
768. 
No functional outcome 
measure (uses employment 
data rather than a functional 
outcome scale) 
Bell, M., Bryson, G., & Wexler, B. E. (2003). Cognitive 
remediation of working memory deficits: durability of 
training effects in severely impaired and less severely 
impaired schizophrenia. Acta Psychiatrica Scandinavica, 
108(2), 101–109. 
No functional outcome 
measure 
Bell, M. D., Bryson, G. J., Greig, T. C., Fiszdon, J. M., & 
Wexler, B. E. (2005). Neurocognitive enhancement 
therapy with work therapy: Productivity outcomes at 6- 
and 12-month follow-ups. The Journal of Rehabilitation 
Research and Development, 42(6), 829. 
No functional outcome 
measure (uses employment 
data rather than a functional 
outcome scale) 
Bell, M. D., Fiszdon, J. M., & Bryson, G. (2009). 
Attention training in schizophrenia: Differing responses 
to similar tasks. Journal of Psychiatric Research, 43(4). 
No control group 
Bell, M. D., Zito, W., Greig, T., & Wexler, B. E. (2008). 
Neurocognitive enhancement therapy with vocational 
services: Work outcomes at two-year follow-up. 
Schizophrenia Research, 105(1-3), 18–29. 
No functional outcome 
measure (uses employment 
data rather than a functional 
outcome scale) 
Bell, M., Fiszdon, J., Greig, T., Wexler, B., & Bryson, G. 
(2007). Neurocognitive enhancement therapy with 
work therapy in schizophrenia: 6-month follow-up of 
neuropsychological performance. The Journal of 
Rehabilitation Research and Development, 44(5), 761. 
No functional outcome 
measure 
Bell, M., Zito, W., Greig, T., & Wexler, B. E. (2008). 
Neurocognitive Enhancement Therapy and Competitive 
Employment in Schizophrenia: Effects on Clients with 
Poor Community Functioning. American Journal of 
Psychiatric Rehabilitation, 11(2), 109–122. 
No functional outcome 
measure (uses employment 
data rather than a functional 
outcome scale) 
Bellucci, D. M., Glaberman, K., & Haslam, N. (2003). 
Computer-assisted cognitive rehabilitation reduces 
negative symptoms in the severely mentally ill. 
Schizophrenia Research, 59(2), 225–232. 
No functional outcome 
measure 








attention deficits in chronic schizophrenic patients: a 
preliminary study. British Journal of Clinical Psychology, 
28(2), 187–188. 
measure 
Benedict, R. H., Harris, A. E., Markow, T., McCormick, J. 
A., Nuechterlein, K. H., & Asarnow, R. F. (1994). Effects 
of attention training on information processing in 
schizophrenia. Schizophrenia Bulletin, 20(3), 537–546. 
No functional outcome 
measure 
Bor, J., Brunelin, J., d’ Amato, T., Costes, N., Suaud-
Chagny, M.-F., Saoud, M., & Poulet, E. (2011). How can 
cognitive remediation therapy modulate brain 
activations in schizophrenia? Psychiatry Research: 
Neuroimaging, 192(3), 160–166.  
No functional outcome 
measure 
Bosia, M., Bechi, M., Marino, E., Anselmetti, S., Poletti, 
S., Cocchi, F., Smeraldi, E., & Cavallaro, R. (2007). 
Influence of catechol-O-methyltransferase Val158Met 
polymorphism on neuropsychological and functional 
outcomes of classical rehabilitation and cognitive 
remediation in schizophrenia. Neuroscience Letters, 
417(3), 271–274. 
No valid control condition 
(Both treatment and control 
group involve treatment 
targeting neuropsychological 
functioning) 
Bowie, C. R., Grossman, M., Gupta, M., Oyewumi, L. K., 
& Harvey, P. D. (2014). Cognitive remediation in 
schizophrenia: efficacy and effectiveness in patients 
with early versus long-term course of illness. Early 
Intervention in Psychiatry, 8(1), 32–38.  
No valid control condition 
(Involves two treatment 
conditions that target 
neuropsychological 
functioning) 
Brown, C., Harwood, K., Hays, C., & Heckman, J. (1993). 
Effectiveness of cognitive rehabilitation for improving 
attention in patients with schizophrenia. Occupational 
Therapy Journal of Research, 13(2), 71–86. 
No valid control condition 
(Involves two treatment 
conditions that target 
neuropsychological 
functioning) 
Burda, P. C., Starkey, T. W., Dominguez, F., & Vera, V. 
(1994). Computer-assisted cognitive rehabilitation of 
chronic psychiatric inpatients. Computers in Human 
Behaviour, 10(3), 359–368. 
No functional outcome 
measure 
Cassidy, J. J., Easton, M., Capelli, C., Singer, A., & 
Bilodeau, A. (1996). Cognitive remediation of persons 
with severe and persistent mental illness. Psychiatric 
Quarterly, 67(4), 313–321. 
No control condition 
Cella, M., Bishara, A. J., Medin, E., Swan, S., Reeder, C., 
& Wykes, T. (2013). Identifying Cognitive Remediation 
Change Through Computational Modelling--Effects on 
Reinforcement Learning in Schizophrenia.  
Non-computerised CR.  No 
randomisation to treatment 
conditions 
Chan, C. L. ., Ngai, E. K. ., Leung, P. K. H., & Wong, S. 
(2009). Effect of the adapted virtual reality cognitive 
training program among Chinese older adults with 
chronic schizophrenia: a pilot study. International 
Journal of Geriatric Psychiatry. 
No functional outcome 
measure 








Greenwald, D. P., Hogarty, S. S., & Keshavan, M. S. 
(2010). Neuroprotective effects of cognitive 
enhancement therapy against gray matter loss in early 
schizophrenia. Arch Gen Psychiatry, 67(7), 674–682. 
measure 
Eack, S. M., Mesholam-Gately, R. I., Greenwald, D. P., 
Hogarty, S. S., & Keshavan, M. S. (2013). Negative 
symptom improvement during cognitive rehabilitation: 
Results from a 2-year trial of Cognitive Enhancement 
Therapy. Psychiatry Research, 209(1), 21–26.  
No functional outcome 
measure 
Edwards, B. G. ., Barch, D. M., & Braver, T. S. (2010). 
Improving prefrontal cortex function in schizophrenia 
through focused training of cognitive control. Frontiers 
in Human Neuroscience. 
No randomisation.  
Participants in control 
condition did not have 
schizophrenia or 
schizoaffective disorder 
Farreny, A., Aguado, J., Ochoa, S., Haro, J. M., & Usall, J. 
(2013). The role of negative symptoms in the context of 
cognitive remediation for schizophrenia. Schizophrenia 
Research, 150(1), 58–63.  
Non-computerised CR 
Field, C. D., Galletly, C., Anderson, D., & Walker, P. 
(1997). Computer-aided cognitive rehabilitation: 
possible application to the attentional deficit of 
schizophrenia, a report of negative results. Perceptual 
and Motor Skills, 85(3), 995–1002. 
No randomisation 
Fiszdon, J. M., Whelahan, H., Bryson, G. J., Wexler, B. E., 
& Bell, M. D. (2005). Cognitive training of verbal 
memory using a dichotic listening paradigm: impact on 
symptoms and cognition. Acta Psychiatrica 
Scandinavica, 112(3), 187–193.  
No functional outcome 
measure 
Fiszdon, J.M., Choi, J., Bryson, G. J., & Bell, M. D. (2006). 
Impact of intellectual status on response to cognitive 
task training in patients with schizophrenia. 
Schizophrenia Research, 87(1-3), 261–269.  
No functional outcome 
measure 
Fiszdon, Joanna M, Bryson, G. J., Wexler, B. E., & Bell, 
M. D. (2004). Durability of cognitive remediation 
training in schizophrenia: performance on two memory 
tasks at 6-month and 12-month follow-up. Psychiatry 
Research, 125(1), 1–7.  
No functional outcome 
measure 
Fiszdon, Joanna M., Cardenas, A. S., Bryson, G. J., & 
Bell, M. D. (2005). Predictors of Remediation Success 
on a Trained Memory Task: The Journal of Nervous and 
Mental Disease, 193(9), 602–608.  
No functional outcome 
measure 
Franck, N., Duboc, C., Sundby, C., Amado, I., Wykes, T., 
Demily, C., … Vianin, P. (2013). Specific vs general 
cognitive remediation for executive functioning in 
schizophrenia: A multicenter randomized trial. 
Schizophrenia Research, 147(1), 68–74. 
Non-computerised CR 








remediation on neurocognitive functions and 
psychiatric symptoms in schizophrenia inpatients. 
Schizophrenia Research, 142(1-3), 165–170.  
Greenwood, K., Hung, C.-F., Tropeano, M., McGuffin, P., 
& Wykes, T. (2011). No association between the 
Catechol-O-Methyltransferase (COMT) val158met 
polymorphism and cognitive improvement following 
cognitive remediation therapy (CRT) in schizophrenia. 
Neuroscience Letters, 496(2), 65–69.  
Non-computerised CR 
Greig, T., Zito, W., Wexler, B., Fiszdon, J., & Bell, M. 
(2007). Improved cognitive function in schizophrenia 
after one year of cognitive training and vocational 
services. Schizophrenia Research, 96(1-3), 156–161. 
No functional outcome 
measure 
Haut, K. M., Lim, K. O., & MacDonald, A. (2010). 
Prefrontal cortical changes following cognitive training 
in patients with chronic schizophrenia: effects of 
practice, generalization, and specificity. 
Neuropsychopharmacology, 35(9), 1850–1859. 
No functional outcome 
measure 
Hermanutz, M., & Gestrich, J. (1991). Computer-
assisted attention training in schizophrenics. European 
Archives of Psychiatry and Clinical Neuroscience, 240(4-
5), 282–287. 
No functional outcome 
measure 
Hooker, C. I., Bruce, L., Fisher, M., Verosky, S. C., 
Miyakawa, A., D’Esposito, M., & Vinogradov, S. (2013). 
The influence of combined cognitive plus social-
cognitive training on amygdala response during face 
emotion recognition in schizophrenia. Psychiatry 
Research: Neuroimaging, 213(2), 99–107.  
No randomisation 
Hooker, C. I., Bruce, L., Fisher, M., Verosky, S. C., 
Miyakawa, A., & Vinogradov, S. (2012). Neural activity 
during emotion recognition after combined cognitive 
plus social cognitive training in schizophrenia. 
Schizophrenia Research, 139(1-3), 53–59.  
No randomisation 
Horan, W. P., Kern, R. S., Tripp, C., Hellemann, G., 
Wynn, J. K., Bell, M., … Green, M. F. (2011). Efficacy and 
specificity of Social Cognitive Skills Training for 
outpatients with psychotic disorders. Journal of 
Psychiatric Research, 45(8), 1113–1122.  
Includes participants with 
diagnoses other than 
schizophrenia or 
schizoaffective disorder 
Ikezawa, S., Mogami, T., Hayami, Y., Sato, I., Kato, T., 
Kimura, I., … Nakagome, K. (2012). The pilot study of a 
Neuropsychological Educational Approach to Cognitive 
Remediation for patients with schizophrenia in Japan. 
Psychiatry Research, 195(3), 107–110.  
No functional outcome 
measure 
Kidd, S. A., Kaur Bajwa, J., McKenzie, K. J., Ganguli, R., & 
Haji Khamneh, B. (2012). Cognitive Remediation for 
Individuals with Psychosis in a Supported Education 
Setting: A Pilot Study. Rehabilitation Research and 








Practice, 2012, 1–5. 
Kontis, D., Huddy, V., Reeder, C., Landau, S., & Wykes, 
T. (2013). Effects of Age and Cognitive Reserve on 
Cognitive Remediation Therapy Outcome in Patients 
With Schizophrenia. The American Journal of Geriatric 
Psychiatry, 21(3), 218–230. 
No valid control condition 
(Involves two treatment 
conditions that target 
neuropsychological 
functioning) 
Kurtz, M. M., Seltzer, J. C., Fujimoto, M., Shagan, D. S., 
& Wexler, B. E. (2009). Predictors of change in life skills 
in schizophrenia after cognitive remediation. 
Schizophrenia Research, 107(2-3), 267–274.  
No control group 
Kurtz, M. M., Seltzer, J. C., Shagan, D. S., Thime, W. R., 
& Wexler, B. E. (2007). Computer-assisted cognitive 
remediation in schizophrenia: What is the active 
ingredient? Schizophrenia Research, 89(1-3), 251–260.  
No functional outcome 
measure 
Kurtz, M. M., Wexler, B. E., Fujimoto, M., Shagan, D. S., 
& Seltzer, J. C. (2008). Symptoms versus neurocognition 
as predictors of change in life skills in schizophrenia 
after outpatient rehabilitation. Schizophrenia Research, 
102(1), 303–311. 
No control group 
Lewandowski, K. E., Eack, S. M., Hogarty, S. S., 
Greenwald, D. P., & Keshavan, M. S. (2011). Is cognitive 
enhancement therapy equally effective for patients 
with schizophrenia and schizoaffective disorder? 
Schizophrenia Research, 125(2-3), 291–294.  
No randomisation 
Lewis, L., Unkefer, E. P., O’Neal, S. K., Crith, C. J., & 
Fultz, J. (2003). Cognitive Rehabilitation with Patients 
Having Persistent, Severe Psychiatric Disabilities. 
Psychiatric Rehabilitation Journal, 26(4), 325–331. 
Non-computerised CR 
Lindenmayer, J.-P., McGurk, S. R., Khan, A., Kaushik, S., 
Thanju, A., Hoffman, L., … Herrmann, E. (2013). 
Improving Social Cognition in Schizophrenia: A Pilot 
Intervention Combining Computerized Social Cognition 
Training With Cognitive Remediation. Schizophrenia 
Bulletin, 39(3), 507–517.  
No valid control condition 
(Involves two treatment 
conditions that target 
neuropsychological 
functioning) 
Lindenmayer, Jean-Pierre, McGurk, S. R., Mueser, K., 
Khan, A., Wance, D., Hoffman, L., … Xie, H. (2008). A 
randomized controlled trial of cognitive remediation 
among inpatients with persistent mental illness. 
Psychiatric Services, 59(3), 241–247. 
No functional outcome 
measure 
López-Luengo, B., & Vázquez, C. (2003). Effects of 
Attention Process Training on cognitive functioning of 
schizophrenic patients. Psychiatry Research, 119(1-2), 
41–53. 
Non-computerised CR 
Mak, M., Samochowiec, J., Tybura, P., Bienkowski, P., 
Karakiewicz, B., Zaremba-Pechmann, L., & Mroczek, B. 
(2013). The efficacy of cognitive rehabilitation with 
RehaCom programme in schizophrenia patients: The 









role of selected genetic polymorphisms in successful 
cognitive. Annals of Agricultural and Environmental 
Medicine, 20(1), 77–81. 
Man, D., Law, K., & Chung, R. (2012). Cognitive training 
for Hong Kong Chinese with schizophrenia in vocational 
rehabilitation. Hong Kong Medical Journal, 18(6), 18–
22. 
No valid functional outcome 
measure 
McGurk, S., Mueser, K., Feldman, K., Wolfe, R., & 
Pascaris, A. (2007). Cognitive training for supported 
employment: 2-3 year outcomes of a randomized 
controlled trial. American Journal of Psychiatry, 164(3), 
437–441. 
Includes participants with 
diagnoses other than 
schizophrenia or 
schizoaffective disorder 
McGurk, S. R., Mueser, K., & Pascaris, A (2005). 
Cognitive Training and Supported Employment for 
Persons With Severe Mental Illness: One-Year Results 
From a Randomized Controlled Trial. Schizophrenia 
Bulletin, 31(4), 898–909.  
Includes participants with 
diagnoses other than 
schizophrenia or 
schizoaffective disorder 
McGurk, S. R., & Mueser, K. T. (2008). Response to 
Cognitive Rehabilitation in Older Versus Younger 
Persons with Severe Mental Illness. American Journal of 
Psychiatric Rehabilitation, 11(1), 90–105.  
Includes participants with 
diagnoses other than 
schizophrenia or 
schizoaffective disorder 
McGurk, S. R., Mueser, K. T., DeRosa, T. J., & Wolfe, R. 
(2009). Work, Recovery, and Comorbidity in 
Schizophrenia: A Randomized Controlled Trial of 
Cognitive Remediation. Schizophrenia Bulletin, 35(2), 
319–335.  
Includes participants with 
diagnoses other than 
schizophrenia or 
schizoaffective disorder 
McGurk, Susan R., Schiano, D., Mueser, K. T., & Wolfe, 
R. (2010). Implementation of the thinking skills for work 
program in a psychosocial clubhouse. Psychiatric 
Rehabilitation Journal, 33(3), 190–199. 
No control group 
Medalia, A., Aluma, M., Tryon, W., & Merriam, A. E. 
(1998). Effectiveness of attention training in 
schizophrenia. Schizophrenia Bulletin, 24(1), 147–152. 
No functional outcome 
measure 
Medalia, A., Revheim, N., & Casey, M. (2000). 
Remediation of memory disorders in schizophrenia. 
Psychological Medicine, 30(06), 1451–1459. 
No functional outcome 
measure 
Medalia, A., Revheim, N., & Casey, M. (2001). The 
remediation of problem-solving skills in schizophrenia. 
Schizophrenia Bulletin, 27(2), 259. 
No functional outcome 
measure 
Medalia, A., Revheim, N., & Casey, M. (2002). 
Remediation of problem-solving skills in schizophrenia: 
evidence of a persistent effect. Schizophrenia Research, 
57(2), 165–171. 
No functional outcome 
measure 
Murthy, N. V., Mahncke, H., Wexler, B. E., Maruff, P., 
Inamdar, A., Zucchetto, M., … Alexander, R. (2012). 
Computerized cognitive remediation training for 
schizophrenia: an open label, multi-site, multinational 








methodology study. Schizophrenia Research, 139(1), 
87–91. 
Olbrich, R., & Mussgay, L. (1990). Reduction of 
schizophrenic deficits by cognitive training: an 
evaluative study. European Archives of Psychiatry and 
Neurological Sciences, 239(6), 366–369. 
Non-computerised CR 
Panizzutti, R., Hamilton, S. P., & Vinogradov, S. (2013). 
Genetic correlate of cognitive training response in 
schizophrenia. Neuropharmacology, 64, 264–267. 
No functional outcome 
measure 
Penadés, R, Boget, T., Lomena, F., Mateos, J. ., Catalan, 
R., Gastó, C., & Salamero, M. (2002). Could the 
hypofrontality pattern in schizophrenia be modified 
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Appendix 1.5 – Description of Outcome Measures Used Across Studies 
Outcome name Abbreviation Assessment 
Modality 
Description 
1. Adaptive composite AC Performance 
based 
Composite of UPSA (see below), Maryland 
Assessment of Social Competence, and Advanced 
Finances Test.  Aims to measure “functional 
competence”, defined as “skills that are important for 
independent living” (Bowie et al, 2012) 
2. The Interview for the 
Assessment of Disability 
AD Interview 
based 
Focuses on personal and social functioning over the 
past month.  Covers work and social functioning 
among other areas. 
3. Social Autonomy Scale EAS Clinician rated Assesses skills in the following areas: personal care, 
management of daily life, resource management, 
external relations, emotional and social relationships 
4. Global Assessment of 
Functioning 
GAF Clinician rated Rates social, occupational and psychological 
functioning on a single item scale 
5. Health of the Nation 
Outcome Scale 
HoNOS Clinician rated Assesses individuals with severe mental illness in 12 
scales covering the following domains: psychiatric 
symptoms, physical health, functioning, relationships, 
and housing, 
6. Life Skills Profile LSP Clinician rated Covers the following domains: self-care; 
nonturbulence; social contact; communication; and 
responsibility. 




Involves role-playing tasks involved in managing 
medication (e.g. taking medication at the appropriate 
time) 




Measures social functioning across four domains: 








relationships, self-care, and disturbing and aggressive 
behaviour. 
9. Quality of life scale QLS Interview 
based 
Assesses individuals’ functioning across four 
functional domains: interpersonal relationships; 
symptoms; work performance; and other community 
activities. 
10. Social Adjustment SA Interview 
based/clinician 
rated 
Composite measure of “functional outcomes in the 
domains of social and vocational functioning, and 
adjustment in major life roles” (Eack et al, 2009) 




Measures functioning across the following domains: 
self-maintenance; social functioning; and community 
living skills. 
12. Social and Occupational 
Functioning Scale 
SOFAS Clinician rated A single-item measure of social functioning 
13. Schizophrenia Quality of 
Life 
SQoL Self-report Assesses the following areas: psychosocial 
functioning; motivation and energy; and 
symptoms/side-effects. 




Involves role-playing tasks relating to day-to-day 
social interactions with the aim of evaluating social 
competence (e.g. meeting a new neighbour). 
15. University of California San 
Diego Performance-Based 
Skills Assessment Battery 
UPSA Performance 
based 
Assesses individuals’ ability to perform the following 
community functioning skills: managing money; 
communication; planning recreational activities; using 
transport; and completing household tasks. 




Assesses work performance across the following 
categories: social skills; cooperativeness; work habits; 
work quality; and personal presentation.  
Assessments are made on the basis of observations 








17. World Health Organization 
Quality of Life-BREF 
WHOQOL-
Bref 
Self-report Assesses the following domains: physical health; 





Chapter 2: Journal Article 
The following journal article reports on the findings of a study investigating the 
implementation of computer assisted cognitive remediation in a high secure forensic 
psychiatric hospital.  The article was written for submission to the International Journal of 












Title: Implementing Computer Assisted Cognitive Remediation in a High Secure Forensic 
Psychiatric Setting 
 
Shortened title: Computerised Cognitive Remediation in High Security 
 
As both schizophrenia and offending behaviour are associated with cognitive deficits, 
computer assisted cognitive remediation (CACR) may benefit a forensic psychiatric 
population.  This study explores the implementation of CACR in a high secure forensic 
psychiatric hospital.  A high attrition rate was found, along with poor adherence to the 
treatment protocol.  No clinical, risk or demographic factors distinguished treatment 
completers from those dropping out during treatment.  An intention-to-treat analysis 
(n=20) found few improvements to performance on computer-based treatment activities or 
functional outcome measures.  Motivational issues may have undermined outcomes, while 
functional deficits may be an inappropriate treatment target in this setting. 
 










Cognitive deficits have been described as a “core feature” of schizophrenia (Minzenberg & 
Carter, 2012) and are thought to be a significant contributor to the disabling difficulties 
with real-world functioning associated with the diagnosis (Green, Kern, Braff, & Mintz, 
2000).  This has led to the development of cognitive remediation therapy (CR), a group of 
interventions “targeting cognitive deficit (attention, memory, executive function, social 
cognition or meta cognition) using scientific principles of learning with the ultimate goal of 
improving functional outcomes” (McGurk et al., 2013). 
 
Cognitive deficits, in areas such as executive functioning, have also been strongly associated 
with offending behaviour (e.g. Ogilvie, Stewart, Chan, & Shum, 2011).   This has led to the 
suggestion that CR may also be beneficial to a forensic population, not only by contributing 
to risk management (O’Rourke, 2013) but also by enhancing outcomes of treatment 
programmes (Ross & Hoaken, 2010).  For high secure forensic psychiatric settings, the 
benefits of CR may be twofold, given the offending history of many patients and the high 




The term CR covers a broad array of different interventions.  Some deliver treatment using 
pencil-and-paper methods (e.g. Sanchez et al., 2014) while others use computer based 
activities (e.g. Dickinson et al., 2010).  Some deliver CR as a stand-alone therapy (e.g. Fisher 
et al., 2014) while others integrate CR with interventions designed to generalise 
neuropsychological gains to functional outcomes (e.g. Bowie, McGurk, Mausbach, 
Patterson, & Harvey, 2012).  Some employ strategy-based approaches to circumvent 
cognitive deficits (e.g. Twamley, Vella, Burton, Heaton, & Jeste, 2012), while others use 
“drill and practice” methods to restore cognitive functioning (e.g. Bucci et al., 2013).  Drill 
and practice approaches are generally based on the premise that improvements to 








will in turn generalise to ‘functional capacity’, a construct encompassing the skills 
underpinning real-world functioning (Medalia & Saperstein, 2013).  CR usually involves two 
or three sessions of training per week, with participants in CR studies completing an 
average of 32 hours of treatment over 17 weeks (Saperstein & Kurtz, 2013).  It should be 
emphasised that there is considerable variability in the dose delivered in CR studies 
(Medalia & Choi, 2009) with some studies finding significant changes in cognitive 
functioning following fewer than 20 hours of training (e.g. McGurk, Mueser, & Pascaris, 
2005) 
 
Evidence base for CR 
A meta-analysis by Wykes, Huddy, Cellard, et al. (2011) provides support for the 
effectiveness of CR in improving cognitive functioning and, in turn, psychosocial 
functioning.  Studies also suggest that CR may lead to improvements in negative symptoms 
(Sanchez et al., 2014) and self-esteem (Garrido et al., 2013). 
 
A meta-analysis looking specifically at computer-assisted cognitive remediation (CACR) also 
found that cognitive outcomes improved following treatment, however a lack of studies 
employing a functional outcome measure precluded an examination of the effect of CACR 
on psychosocial functioning (Grynszpan et al., 2011).  The generalisation of cognitive gains 
to functional outcomes may be largely dependent on the delivery of a concurrent 
intervention targeting the skills underpinning functional capacity (Wykes et al., 2011; 
Gallagher, 2014) and may also be influenced by real-world opportunities to practice and 
develop these skills (Holshausen, Bowie, Mausbach, Patterson, & Harvey, 2014).   
 
Despite the potential benefits of CR for a forensic population, there appear to be few 
studies in the peer-reviewed literature that explore the efficacy or acceptability of CR with 








Hoaken, 2014) piloted CR with female prisoners and provided some preliminary evidence 
that CR may be effective with this population. 
 
Although the empirical evidence appears to indicate CR is effective, the methodological 
quality of CR studies has been criticised (Gallagher, 2014) with higher quality studies often 
failing to support the efficacy of CR (e.g. Dickinson et al., 2010).  As a result of these issues, 
there has been some reluctance to endorse CR as a recommended treatment for 
schizophrenia (e.g. NICE, 2009).  Nonetheless, advocates for CR maintain that the 
methodological quality of studies does not bias outcomes and that the next phase of CR 
research should focus on implementation issues such as attrition rates and other 
assessments of acceptability (Wykes et al., 2011). 
 
Acceptability studies 
Few studies appear to have explicitly focused on acceptability.  Wykes et al. (2011) point 
out that the average attrition rates from CR studies (11%; Saperstein & Kurtz, 2013) will not 
necessarily reflect the acceptability of CR or be applicable to clinical settings as payments 
are often made to participants in research trials.  Furthermore, there is considerable 
variation in attrition across studies, with many finding rates notably above average, such as 
48% in a study recruiting inpatients (Byrne et al., 2013) and 30% in a study delivering CACR 
in participants’ homes (Fisher et al., 2014), suggesting treatment setting may have an 
influence on attrition. 
 
Attention has turned to identifying other factors that may influence attrition rates in CR 
studies.  Motivation has been identified as a key element in retaining participants in CR 
interventions, with intrinsic rather an extrinsic motivation thought to be most significant 
factor (Medalia & Choi, 2009; Saperstein & Kurtz, 2013).  Twamley, Burton, & Vella (2011) 
explored the potential clinical, cognitive or demographic factors that may predict 








Although they found no differences between those who dropped out during treatment and 
those who completed, they did find that participants who dropped out of their study before 
beginning treatment had lower levels of education than those who completed (Twamley et 
al., 2011). 
 
Attrition from forensic interventions has been the subject of extensive research.  This likely 
reflects the challenges involved in engaging antisocial individuals in treatment programmes 
(Wormith & Olver, 2002) which has contributed significantly to the lack of empirical 
evidence for psychological interventions with forensic psychiatric patients (Forensic Mental 
Health Matrix Working Group, 2011).   A meta-analysis by Olver, Stockdale, & Wormith 
(2011) identified a wide range of factors that predict attrition from forensic interventions, 
including younger age; a longer sentence; lower scores on assessments of intelligence; a 
diagnosis of anti-social personality disorder (ASPD); a history of substance misuse; and a 
higher risk of future offending.  Symptoms of psychosis have also been associated with 
higher attrition rates (Van Stelle, Blumer, & Moberg, 2004). 
 
As with CR studies, significant attention has been paid in the forensic treatment literature 
to the subject of motivation, a key aspect in the successful delivery of psychological 
interventions with forensic psychiatric patients (Forensic Mental Health Matrix Working 
Group, 2011).  Lower levels of motivation have been highlighted as another factor 
associated with higher attrition rates (Olver et al., 2011), however institutional treatment 
settings have been associated with lower attrition rates, possibly due to external motivating 
factors, such as early release (Olver et al., 2011). 
 
Aims 
In summary, CR appears to have the potential to provide significant benefits to high secure 
forensic psychiatric patients, however there may also be significant challenges faced in the 








implementation of CACR in a high secure forensic psychiatric hospital to help inform 
service-based decisions about the use of CACR as a clinical intervention, as well as 
informing decisions about conducting further efficacy studies of CACR in this type of 
setting.  The study will aim to explore the following research questions: 
 
1. Can CACR be successfully implemented within a high secure forensic environment? 
It is hypothesised that 1) the attrition rate will be similar to the average attrition rate in CR 
studies (11%; Saperstein & Kurtz, 2013); and 2) participants completing treatment will 
attend for a mean of 3 sessions per week, as planned in the treatment protocol (see Table 1 
below for further details). 
 
2. Are there significant differences between those who complete treatment and those who 
don’t? 
Based on the predictors of treatment attrition identified in the studies by Olver et al. (2011) 
and Van Stelle et al. (2004), it is hypothesised that in comparison to treatment completers, 
those dropping out of treatment either before or during treatment will: be younger; have 
had a longer stay in the hospital; score higher on a measure of risk of violence; score higher 
on measures of psychosis symptoms; and score lower on a measure of insight, a construct 
commonly covered in violence risk assessments (e.g. Webster, Douglas, Eaves, & Hart, 
1997). 
 
3. Is CACR associated with improvements to performance on treatment activities, as well as 
clinical and functional outcomes? 
It is hypothesised that performance on treatment activities (i.e. CACR modules) will 
improve following CACR, along with scores on measures of functional capacity, negative 








psychological distress will also be explored.  It is hypothesised that improvements will be 
sustained over a three month period. 
Methods 
Design 
The study employed an uncontrolled pre/post-test design. 
 
Participants 
Participants were inpatients recruited from a high secure forensic psychiatric hospital.  Due 
to the admission requirements of the hospital, all participants were male, aged 18 or over, 
and required conditions of special security to manage the risk of violence or sexual 
violence.  While participating in CACR treatment, all participants continued to be offered 
the standard care and treatment available within the hospital.  Treatment plans are tailored 
to each individual according to clinical need and may include medical, nursing, occupational 
therapy and other psychological interventions. 
 
Participants were considered eligible for CACR if there was an indication that their cognitive 
functioning may have been reduced as a result of one or more of the following factors: a 
diagnosis of schizophrenia; a prior head injury; or diagnosis of alcohol or substance abuse.  
Participants were ineligible for treatment if they had a diagnosed or suspected neurological 
condition, or if they had any known cognitive deficits thought to significantly impair their 
functioning. 
 
An a-priori power calculation was conducted to determine the sample size required for the 
study.  Given that improving day-to-day functioning is the ultimate goal of CACR, the effect 
size found for functional outcomes in the meta-analysis by Wykes et al. (2011) was used for 
the calculation (E.S. = 0.42).  For a repeated-measures within-groups ANOVA, using an alpha 










In addition to the measures outlined below, baseline demographic data was obtained from 
participants’ files. 
Cognitive functioning: The MATRICS Consensus Cognitive Battery (MCCB; Nuechterlein et 
al., 2008) covers the core neuropsychological domains thoughts to be affected in 
individuals diagnosed with schizophrenia.  For the purposes of this study, the composite t-
score covering performance on all 10 subtests of the MCCB was used to assess participants’ 
baseline cognitive functioning.  The MCCB has demonstrated good internal consistency 
(Cronbach’s alpha = 0.76; Burton et al., 2013) and good test-retest reliability for the 
composite score (intraclass correlation coefficient = 0.90; Nuechterlein et al., 2008).  A copy 
of the MCCB materials is not included in appendices due to copyright restrictions.   
 
Risk of violence: The Historical, Clinical and Risk Management-20 (HCR-20; (Webster et al., 
1997) covers static (historical) and dynamic (clinical; risk) factors that have been shown to 
predict future violence.  Each of the 20 items is rated on a 3-point scale.  In this study, 
scores for each subscale were used (historical, clinical and risk) along with the total score.  
The HCR-20 has been shown to have excellent internal consistency (Cronbach’s alpha = 
0.95; Belfrage, 1998) and good test-retest reliability (intraclass correlation coefficient = 
0.80; Douglas & Webster, 1999))    A copy of a HCR-20 scoring document can be found in 
Appendix 2.2. 
 
Symptoms of psychosis: The abbreviated version of the Psychosis Evaluation Tool for 
Common Use by Caregivers (PECC; Hert et al., 2002) evaluates 8 symptom items on a 7-
point scale. Symptoms are grouped to provide scores across three factors: positive 
(hallucinations, delusions, unusual thought content, grandiosity), negative (blunted affect), 
depressive (depression, feelings of guilt, somatic concerns).  Scores for the positive and 
negative scales were used for this study.  Although the full version of the PECC has been 








characteristics have not been reported in the literature.  A copy of the PECC scoring 
guidance document can be found in Appendix 2.3. 
 
Insight: The Behavioural Status Index (BEST; Woods, Reed, & Robinson, 1999) covers 150 
items, rated on a 5-point scale.  It aims to assess performance on a range of life skills.  For 
the purposes of this study, only the total score for the 20-item ‘Insight’ sub-scale was used 
which aims to measure individuals’ insight into the nature of their problems and their own 
role in the development of these problems.  The BEST has been shown to have good test-
retest reliability (intraclass correlation coefficient = 0.84; Woods et al., 1999) however the 
internal consistency of the measure has not been adequately reported.  A copy of the items 
that constitute the BEST Insight scale can be found in Appendix 2.4. 
 
 Outcome measures 
Functional capacity: The University of California San Diego Performance Based Skills 
Assessment (UPSA; Patterson, Goldman, McKibbin, Hughs, & Jeste, 2001) tests a range of 
skills related to independent community living (household tasks; communication; finance; 
transportation; planning recreational activities) and provides an overall score out of 100.  A 
recent study has indicated that individuals’ scoring 75 out of 100 are likely to be capable of 
independent living (Mausbach et al., 2008).  Minor adaptations were made across a range 
of areas to make the UPSA more culturally relevant to UK-based participants (e.g. changing 
the currency from dollars to pounds) and to ensure the items required for assessment tasks 
complied with hospital security regulations.  All amendments were made following 
discussions between members of the research team to ensure that changes were kept to a 
minimum.  The original UPSA manual can be found in Appendix 2.5, while the amended 
version is in Appendix 2.6.  The UPSA has been shown to have good test-retest reliability 
(intraclass correlation coefficient = 0.93; Harvey, Velligan, & Bellack, 2007) however the 









Negative Symptoms: The Clinical Assessment Interview for Negative Symptoms (Version 1) 
(CAINS; Forbes et al., 2010) is a measure of the negative symptoms of psychosis.  The 13 
items of the CAINS are evaluated on the basis of a semi-structured clinical interview.  Scores 
are derived on a scale measuring motivation and pleasure, and a second subscale 
measuring expression, which can be combined into a total score (Horan, Kring, Gur, Reise, 
& Blanchard, 2011).  For the purposes of this study, the subscale scores will be reported 
rather than the total score as these are thought to represent two distinct treatment targets 
(Kring, Gur, Blanchard, Horan, & Reise, 2013).  The CAINS has been shown to have good 
internal consistency (Cronbach’s alpha = 0.76; Kring et al., 2013) and good test-retest 
reliability (intraclass correlation coefficients = 0.93 for motivation and pleasure subscale 
and 0.77 for expression subscale; Kring et al., 2013).  A copy of the CAINS interview 
schedule and scoring guide can be found in Appendix 2.7. 
 
Self-Esteem/Self-Image: The Self-Image Profile for Adults (SIP-AD; Butler & Gasson, 2006) is 
a 30 item self-report scale, measuring both self-esteem (SIP-SE) and self-image (SIP-SI).  For 
each item (e.g. ‘optimistic’), participants provide responses on how they see themselves, as 
well as how they would like to be.  The SIP-AD has been shown to have excellent internal 
consistency (Cronbach’s alpha = 0.90; Butler & Gasson, 2006) however test-retest reliability 
has not been reported in the literature.  A copy of the SIP-AD is not included in appendices 
due to copyright restrictions.   
 
Psychological distress: The Clinical Outcomes in Routine Evaluation – Outcome Measure 
(CORE; Evans et al., 2002) is a 34 item self-report questionnaire designed to measure 
problem severity and change following psychological interventions.  Responses are marked 
on a 5-point scale from “not at all” to “most or all of the time”.  It covers four different 
domains (subjective well-being, problems/symptoms, life functioning and risk to self and 
others), however the total score was used for this study.  The CORE has been shown to 
have excellent internal consistency (Cronbach’s alpha = 0.94; Evans et al., 2002) and good 
test-rest reliability (intraclass correlation coefficient = 0.90; Evans et al., 2002).  A copy of 










Treatment adherence/Performance on treatment tasks: The CogniPlus system 
automatically collects data on each CACR session, including the date and length of the 
session, as well as the difficulty level achieved on each task. 
 
Participant feedback : A feedback questionnaire was created for the purposes of the study 
to explore participants’ experiences of the treatment.  This can be found in Appendix 2.9.    
It included six questions about their enjoyment of each of the CogniPlus modules, rated 
from one to five on a Likert scale (1=did not enjoy at all; 5=really enjoyed).  5 other Likert 
scale questions covered participants’ views on: their enjoyment of the training (1=did not 
enjoy at all; 5=Really enjoyed); how interesting they found it (1=not at all interesting; 
5=highly interesting); their perception of improvements to both their memory and 
attention (‘Do you feel that the training has improved your [memory/ability to pay 
attention]; 1=no, not at all; 5=yes, lots); and how likely they would be to recommend it to 
others (1=would definitely not recommend; 5=would definitely recommend).  It also 
included six open-ended questions (‘What did you like about the training’; ‘What are the 
good things that you will take away from the training’; how have you benefited from the 
training’; ‘what did you dislike about the training’; ‘what did you find difficult’; ‘can you 
think of anything to make the training better’). 
 
Procedure 
The study involved two phases.  The initial ‘research’ phase received ethical approval from 
South East Scotland Research Ethics Committee and the local research committee.  A copy 
of the documents confirming ethical and hospital approval for the research phase can be 
found in Appendix 2.10.  After agreeing to speak to researchers following a discussion with 
their responsible medical officer, participants provided written informed consent to 
participate in the study.  A copy of the consent form and participant information sheet can 









Following the completion of the research phase, the intervention was included as part of 
the set of psychological therapies offered within the hospital, with participants referred for 
CACR by the clinical team responsible for their care and treatment.  Approval was given by 
South East Scotland Research Ethics Committee, the local research committee and the 
University of Edinburgh for a service evaluation of CACR to take place (see Appendix 2.12 
for the relevant documents).  Table 1 highlights modifications made between the research 
and service evaluation phases; these are discussed further below. 
 
Treatment 
CogniPlus is a recently developed CACR package that includes a number of key features 
designed to be engaging for participants, with the aim of increasing motivation and 
treatment adherence (Schuhfried, n.d.).  These include the use of real world-tasks and 
scenarios; the use of computer-game style graphics; and the calibration of task difficulty 
levels in response to participant performance to ensure tasks are never too easy or too 
difficult (Schuhfried, n.d.).  Although there is currently little current evidence for the 
efficacy of CogniPlus, it has been designed as an advancement to the same developer’s 
Rehacom system which has been shown to be effective in improving cognitive functioning 
in a number of studies (e.g.  d’ Amato et al., 2011). 
 
Table 1 above indicates the treatment schedule for both the research and service 
evaluation arms of the study, with Table 2 providing a description of the neuropsychological 
domain targeted by each CogniPlus module.  In both arms, treatment was planned to 
consist of 3 phases of equal length consisting of three one-hour sessions per week.  Each 
session involved 2 or more different modules, with equal time spent on each module during 
a session.  The initial phase targeted different aspects of attention, as improvements in 
attention are thought to facilitate improvements in other aspects of patients’ cognitive 
functioning (López-Luengo & Vázquez, 2003).  Subsequent phases continued to target 
attention while also targeting executive functioning and working memory. 
 
 
   
Table 1: A comparison of the Research and Service Evaluation arms of the study 
 Research Service Evaluation 
Treatment schedule 3 sessions per week 
over 14 weeks 
3 sessions per week over 
10 weeks 
Treatment session plan:*   
 Phase 1 ALERT; VIG  
(14 sessions) 
ALERT; VIG; SELECT 
 (10 sessions) 
 Phase 2 ALERT; FOCUS; NBACK; 
PLAND (14 sessions) 
ALERT; FOCUS; NBACK 
(10 sessions) 
 Phase 3 ALERT; SELECT; NBACK 
(14 sessions) 
ALERT; NBACK; PLAND 
(10 sessions) 
*See Table 2 for details of modules 
 
 
   
Table 2 – Neuropsychological domain targeted by 
each CogniPlus module 
Module name Neuropsychological domain 
ALERT Attention: alertness 
VIG Attention: vigilance 
SELECT Attention: selective 
FOCUS Attention: focused 
NBACK Working memory 




All baseline measures were obtained from participants’ files and had been completed by 
trained clinicians as part of the routine clinical work of the hospital, with the exception of 
the MCCB which was used specifically for the purposes of this study.  HCR-20 assessments 
were completed by the multi-disciplinary team responsible for participants’ care, while the 
BEST and PECC were completed by participants’ nursing key-worker. 
 
Outcome measures and the MCCB were completed by various members of the 
psychological therapies team (a trainee clinical psychologist, a nurse practitioner, two 
assistant psychologists and a PhD student).  With the exception of the CAINS, assessors 
were trained in the administration of outcome measures by the consultant 
neuropsychologist overseeing the project.  Two assessors were trained to administer the 
CAINS (the trainee clinical psychologist and the PhD student), which involved rating videos 
of interviews provided by the developers of the tool.  Although “gold-standard” ratings of 
these videos were also provided, assessors’ scores were not formally compared to these.  It 
should also be noted that inter-rater reliability  and rater drift were not assessed for any of 
the outcome measures.  Supervision was provided to all assessors, either in the normal 
course of their clinical work or by the consultant neuropsychologist. 
 
Outcome measures were administered before and after treatment, with follow-up 
assessments planned for three, six and 12 months after the completion of post-treatment 
assessments.   Follow-up assessments were only partially completed at the time of 
submission (see Figure 1 below for details).  Demographic and other baseline information 




All data were assessed for normality and skewness using the Kolmogorov-Smirnov test and 








assess any differences between the research and service evaluation groups in terms of the 
number of hours of CACR completed, both overall and for each module.  Due to the small 
sample size and the exploratory nature of the study, a p-value of 0.05 was used a threshold 
for significance across all tests. 
 
1. Can CACR be successfully implemented within a high secure forensic environment? 
Attrition rates were calculated, both for those dropping out before completing baseline 
assessments and those dropping out during treatment.  Participants were considered to 
have dropped out if they failed to complete at least 20 hours of CACR or if they failed to 
complete at least one session from each planned phase of their treatment. 
 
To assess treatment adherence, means and standard deviations were calculated for the 
number of sessions and hours of CACR completed, as well as the number of weeks in 
treatment and the average number of sessions completed per week.  Calculations were 
completed for the intention to treat sample (ITTS; i.e. all those who completed baseline 
assessments), as well as for those who completed treatment.   
 





2. Are there significant differences between those who complete treatment and those who 
don’t? 
Effect sizes (Cohen’s d) were used to compare those who started treatment and those who 








same comparisons were made between those who completed treatment and those who 
started but dropped out, with the addition of comparisons of baseline scores for each of 
the outcome measures.  Differences were considered significant if the effect size was 
greater than 1. 
 
3. Is the treatment associated with improvements to performance on treatment activities, 
as well as clinical and functional outcomes? 
An intention-to-treat analysis was employed to evaluate the performance of the ITTS on the 
CogniPlus modules, as well as each of the outcome measures.  Missing data was addressed 
using the Last Observation Carried Forward (LOCF) method.  One-way repeated measures 
ANOVAs and Friedman’s tests were used to evaluate change over time.  Effect sizes were 
calculated using Cohen’s d (Cohen, 1992) for all outcome measures, comparing baseline 
scores to post-treatment scores and to follow-up scores.  
 
Due to variability in the number of sessions completed by participants, analyses of 
performance on treatment activities were based on the treatment plan for the service 
evaluation group.  This allows an analysis of performance across a typical treatment plan.  
Where participants completed fewer sessions, a LOCF method was used.  Clearly, it was 
only possible to include participants in these analyses if they had completed at least one 
session on the module.  Due to the initial process of calibrating difficulty levels to 
participant ability, analyses of performance on treatment activities were repeated with the 
first session omitted, as the difficulty level achieved on this session may reflect the 













Demographic details of the participants are summarised in Tables 3 and 4.  Assessments of 
normality and skewness indicated that scores on the following measures were not normally 
distributed: length of admission; HCR-20 (total score only); UPSA scores at baseline; SIP 
scores at post-treatment and 3-month follow-up (but not baseline); and difficulty levels on 
ALERT, FOCUS, VIG, NBACK modules.  No significant differences were found between the 
hours of treatment completed by participants in the two phases of the study (research 
phase and service evaluation phase) therefore results were combined for subsequent 
analyses.  Figure 1 provides a CONSORT diagram summarising recruitment and retention 
within the study.  Follow-up data was still being collected at the time of writing and six and 
12-month data was omitted from analyses due to the low number of assessment 
completed. 
 
Participants were split into three groups according to their engagement in CACR.  
Individuals dropping out before completing baseline assessments were classed as 
‘Refusers’; those dropping out after baseline assessments were completed were classed as 
‘Dropouts’; with all others classed as ‘Completers’.  In addition, the combination of the 
‘Dropouts’ and ‘Completers’ was defined as the ‘intention-to-treat sample’ (ITTS).   
 
1. Can CACR be successfully implemented within a high secure forensic environment? 
Recruitment  
Overall, 27 individuals agreed to take part in the intervention.  Seven of those dropped out 
before pre-treatment assessments were completed (constituting the ‘Refusers’ group), 
leaving 20 who started the treatment and constituted the intention-to-treat sample (‘ITTS’).  






Table 3 - Baseline data and comparisons between Completers and Drop-outs 
 Completers (n=13) 
Mean (SD) or % 
Drop-outs (n=7) 
Mean (SD) or % 
Effect Size 
Cohen’s d 
Age 41.07 (12.87) 31.66 (9.01) 0.85 
Length of admission 5.42 (7.50) 2.39 (2.13) 0.55 
Baseline MCCB score 29.33 (10.22) 23.67 (10.27) 0.55 
ASPD diagnosis 23.08% 14.29% - 
Substance Abuse 76.92% 100% - 
Primary Diagnosis    
   Schizophrenia 69.23% 100% - 
   Schizoaffective 7.69% 0% - 
   Bipolar disorder 7.69% 0% - 
   Delusional disorder 7.69% 0% - 
   Alcohol psychosis 7.69% 0% - 
HCR-20 Historical 12.67 (4.27) 14.43 (4.16) 0.42 
HCR-20 Clinical 4.92 (1.68) 6.00 (1.73) 0.63 
HCR-20 Risk 5.50 (1.45) 5.00 (1.73) 0.31 
HCR-20 Total 28.92 (21.44) 25.43 (5.91) 0.22 
PECC negative 2.62 (1.67) 2.86 (2.12) 0.13 
PECC positive 7.46 (4.50) 11.57 (6.50) 0.74 
BEST Insight 70.54 (18.74) 67.57 (17.62) 0.16 
CAINS Motivation 14.08 (9.97) 13.86 (8.17) 0.02 
CAINS Expression 5.69 (3.66) 6.00 (4.62) 0.07 
CAINS Total 19.77 (12.94) 19.86 (11.71) 0.01 
SIP Self-image 97.38 (35.13) 109.29 (32.19) 0.35 
SIP Self-esteem 57.15 (27.38) 47.57 (21.96) 0.39 
UPSA 69.62 (15.65) 78.57 (11.34) 0.65 











Table 4 - Baseline data and comparisons between Completers and Refusers 
 Completers (n=13) 
Mean (SD) or % 
Refusers (n=7) 
Mean (SD) or % 
Effect Size 
Cohen’s d 
Age 41.07 (12.87) 49.63 (7.98) 0.80 
Length of admission 5.42 (7.50) 13.68 (6.94) 1.14 
ASPD diagnosis 23.08% 42.86% - 
Substance Abuse 76.92% 71.43% - 
Primary Diagnosis    
   Schizophrenia 69.23% 85.71% - 
   Schizoaffective 7.69% 14.29% - 
   Bipolar disorder 7.69% 0% - 
   Delusional disorder 7.69% 0% - 
   Alcohol psychosis 7.69% 0% - 
HCR-20 Historical 12.67 (4.27) 15.20 (2.78) 0.70 
HCR-20 Clinical 4.92 (1.68) 6.80 (1.79) 1.08 
HCR-20 Risk 5.50 (1.45) 7.00 (2.16) 0.82 
HCR-20 Total 28.92 (21.44) 48.00 (35.16) 0.66 
PECC negative 2.62 (1.67) 2.29 (0.95) 0.24 
PECC positive 7.46 (4.50) 9.14 (2.91) 0.44 





Figure 1 - CONSORT Diagram 
Did not complete initial assessments n=7 
 
Reasons given: 
 Change of medication n=1 
 Time requirements of assessments n=3 
 Not perceiving any difficulties with 
cognitive functioning n=1 
 No reason given n=2 
Commenced treatment n=20 
 
Post-treatment n=20 
 Completed assessments n=17 
 LOCF n=3 
 
6-month follow-up n=20 
 Completed assessments n=6 
 LOCF n=14 
 
3-month follow-up n=20 
 Completed assessments n=14 
 LOCF n=6 
 
Consented to treatment n=27 
 
12-month follow-up n=20 
 Completed assessments n=3 




Retention and treatment adherence 
Of the ITTS, seven participants prematurely ended treatment (constituting the ‘Drop-outs’ 
group).  Reasons given were: finding the treatment tedious and/or struggling to identify any 
potential benefits (n=4); a deterioration in mental state (n=2); and finding it difficult to 
comprehend task instructions (n=1).  The remaining participants constituted the 
‘Completers’ group. 
 
Participants in the ITTS completed a mean of 0.82 hours (SD=0.20) of treatment per session, 
with a mean of 1.77 sessions (SD=0.76) completed per week.  In total, the mean number 
hours of treatment completed by participants in the ITTS was 21.69 hours (SD=13.09) in  a 
mean of 24.80 sessions (SD=14.16), over a mean of 11.96 weeks (SD=6.10).   
 
The Completers group managed a mean of 0.90 hours (SD=0.08) per session, with a mean 
of 2.09 sessions (SD=0.57) completed per week.  In total, the mean number of hours of 
treatment completed by this group was 30.38 (SD=5.28), in a mean of 34.00 sessions 
(SD=6.71), over a mean of 15.32 weeks (SD=4.01).  
 
Feedback 
The feedback form was completed by nine participants from the service evaluation arm of 
the study, a response rate of 69.23%.  As participants were able to return this anonymously 
through the hospital internal mailing system, it is not possible to identify the proportion of 
forms returned by Completers and Dropouts.  Figure 2 shows mean scores on questions 
about participants’ perceptions of the intervention as a whole, while Figure 3 contains 
participants’ ratings of each module.  All questions were scored on a 5-point Likert scale, 








How much did you enjoy
these sessions?
Did you find the training
sessions interesting?
Do you feel that you the
training has improved your
ability to pay attention?
Do you feel that you the
training has improved your
memory?
How likely would you be to
recommend Cogniplus
Training to other patients?
Figure 2: 5-point Likert scale questions assessing participants' 








ALERT VIG SELECT FOCUS NBACK PLAND
Figure 3: 5-point Likert Scale Questions Evaluating 
Participants' Enjoyment of Each Treatment Activity 
 
 
In response to the open-ended questions, participants replied with a number of positive 
comments.  Two respondents remarked on aspects of training that they liked; one indicated 
that that he enjoyed the novelty of the intervention (“It helped me to focus on something 
new”), while another referred to the diversity of modules (“[I enjoyed the] different 
varieties of tasks - different subjects”).  When asked about any improvements following 
training, two participants mentioned perceived improvements to aspects of cognitive 
functioning (“I think I can focus on problems and my memory and alertness are improved”; 
“More alert, more vigilant… can see an improvement [in my memory]”) while another 
seemed to focus more broadly on their mental health (“State of mind”).   
 
A number of less positive comments were also included in the feedback, with five 
respondents mentioning that the intervention was “tedious”, “boring” or “went on too 
long”, with specific mention made of the VIG module.  Three respondents indicated that 
they hadn’t noticed any improvements following CACR. 
 
Only one participant gave advice on how the treatment could be improved, commenting “I 
think rather than [VIG] it would be more therapeutic to do a task 1-1 with a psychologist”. 
 
2. Are there significant differences between those who complete CACR and those who 
don’t? 
Baseline comparisons can be seen in Tables 3 and 4.  Those who completed treatment have 
been compared firstly to those who dropped out, and secondly to those who refused to 
start treatment. 
 
No significant differences were found between Completers and Drop-outs.  However, there 
were significant differences between Completers and Refusers in terms of the length of 










3. Is CACR associated with improvements to performance on treatment activities, as well 
and clinical and functional outcomes? 
Treatment activities 
Figure 4 shows the mean difficulty level achieved on each module at each session by 
participants in the ITTS. This is based on the 30 session treatment plan used in the service 
evaluation phase. 
 
Results of ANOVAs/Friedman’s tests on the treatment activities found significant 
differences over time in terms of difficult ratings for ALERT (χ2(29, n=20) = 64.24, p<0.01); 
SELECT (F(1.76, 29.86) = 11.76, p<0.01), FOCUS (χ2(9, n=15) = 21.10, p=0.01) and PLAND 
(F(1.78, 23.07) = 14.78, p<0.01).  No significant differences over time were found for VIG 
(χ2(9, n=19) = 13.71, p=0.13) or NBACK (χ2(19, n=14) = 13.31, p=0.82).  When the analyses 
were repeated with the initial calibration session removed, both ALERT (χ2(27, n=20) = 
21.75, p=0.05) and FOCUS (χ2(8, n=15) = 8.82, p=0.36) no longer demonstrated any 
significant differences over time. 
 
Clinical and Functional Outcomes 
Table 5 summarises the post-treatment effects for each of the outcome variables used.  
ANOVAs/Friedman’s tests indicate that, over time, participants improved significantly on 
the Motivation and Performance sub-scale of the CAINS (F(1.41, 26.77) = 5.65, p=0.02) and 
the self-esteem scale of the SIP (χ2(3, n=20) = 7.77, p=0.05).  Effect sizes post-treatment 
were small for the significant results, however improvements to the Motivation and 
Performance sub-scale of the CAINS appears to have been largely maintained at the 3-
month follow-up stage.  Post-hoc analyses did not find any significant differences between 





























Figure 4: Mean Difficulty Level Achieved on CogniPlus Modules 
at Each Session Across 30 Session Treatment Plan 




Table 5 - Outcome measures: means, standard deviation, ANOVA/Friedman’s tests, and effect 











Measure Mean SD Mean SD Mean SD F/ χ2 df p Post 
3-
month 
UPSA 72.75 14.65 74.85 11.67 74.10 11.67 1.73* 2 0.42 0.16 0.10 
CAINS            
   Motivation 14.00 9.16 10.40 7.75 9.45 7.42 7.42 1.19 0.01 0.42 0.55 
   Expression 5.80 3.90 4.75 3.88 5.10 3.57 2.00 2 0.15 0.27 0.19 
SIP            
   Self-image 101.55 33.77 109.35 27.46 104.10 31.30 2.13* 2 0.34 0.25 0.08 
   Self-esteem 53.80 25.45 45.95 22.09 47.35 19.15 6.13* 2 0.05 0.33 0.29 
CORE 30.00 20.50 25.60 19.27 27.00 19.53 1.60 2 0.21 0.22 0.15 









CACR has the potential to offer significant benefits to forensic psychiatric patients and the 
current study provides an evaluation of the implementation of CACR in a high secure 
forensic setting.  The broad aims were to explore acceptability by looking at attrition rates 
and treatment adherence data; identify factors that may predict treatment attrition; and 
generate preliminary outcome data. 
 
Over 50% of participants dropped out from the study either before or during treatment, 
compared to an average attrition rate in CR interventions of 11% (Saperstein & Kurtz, 
2013).  Roughly similar attrition rates have been found in other studies conducted across a 
range of treatment settings (e.g. Twamley et al., 2011; Fisher et al., 2014; Byrne et al., 
2013), however this level of attrition has been characterised as “a significant obstacle” in 
previous research (Twamley et al., 2011).  Those who dropped out during treatment were 
indistinguishable from completers, a finding similar to that of Twamley et al. (2011) which 
indicates prematurely ending treatment cannot be explained demographic, clinical, and risk 
factors.  As a result, the only data available to explain attrition are feedback about the 
treatment itself, as well as self-reported reasons for dropping out.  The consistent message 
from these sources of data would appear to be that the treatment was perceived as being 
“boring”, “tedious” and “too long”, with over half the respondents to the feedback 
questionnaire describing the treatment in this way, and over half of those who dropped out 
of treatment explaining their decision using broadly similar terms. 
 
With regards to adherence, participants received a lower ‘dose’ of treatment than planned, 
with the treatment completers only managing an average of two sessions per week rather 
than the planned three sessions.  Nonetheless, the frequency and total amount of 
treatment received by the ITTS exceeds that which has been shown to be sufficient for 
change in previous studies (e.g. McGurk et al., 2005).  So while it would appear that 
participants find it difficult to adhere to the treatment protocol, the evidence would 








setting.  However, despite the adequate dose of CACR received, there was little evidence of 
improvement on two of the six therapy tasks.  Furthermore, two additional therapy tasks 
failed to show any improvements when the initial calibration sessions were removed from 
analyses.  These results are also reflected in scores on the UPSA outcome measure, which 
failed to demonstrate any gains post-treatment.  Although there were post-treatment 
improvements to scores of self-esteem and negative symptoms, it is of course possible that 
these relate to non-specific treatment effects rather than the effects of CACR. 
 
In summary, the evidence suggests that most patients will drop-out at some stage in the 
recruitment and treatment process; that those who do go on to complete treatment don’t 
adhere well to the treatment protocol; and that participants generally don’t appear to 
improve their performance on treatment activities or functional outcome measures, 
despite receiving a potentially adequate dose. 
 
Why such a poor outcome? 
The lack of any improvement on treatment activities could potentially relate to a number of 
different factors, including floor effects on the treatment activities or perhaps simply that 
CogniPlus itself is not effective.  However, participants’ consistent feedback that treatment 
was “boring” may also be an important factor in the failure to find any significant 
improvements to treatment activity performance and UPSA scores.  It is possible that this 
undermined participants’ motivation to engage in, and benefit from, treatment. 
 
Medalia & Choi (2009) highlight the importance of motivation in predicting outcomes in CR 
and suggest that finding a task “interesting and engaging” are the primary features of 
intrinsic motivation.  They also stress that extrinsic motivators can have a negative impact 
on learning (Medalia & Choi, 2009).  The combination of an intervention perceived as 
“boring” and a forensic treatment setting where many of the motivators for individuals to 








Olver et al., 2011) may result in significantly lower levels of motivation to engage in CACR, 
negating some of the inherently motivating aspects of CogniPlus.  This may help to explain 
both the poor adherence to the treatment schedule, as well as the lack of improvement 
across the therapy activities.  A recent review of the CR literature lists a range of different 
approaches that may help address motivational issues, such as relating the remediation of 
cognitive deficits to the attainment of specific intrinsic and extrinsic goals and rewards that 
are meaningful to the participant (Saperstein & Kurtz, 2013).  These ideas and principles 
may provide a guide for adapting the delivery of CACR in high secure forensic settings to 
include a range of motivation-enhancing strategies. 
 
Is functional capacity an appropriate treatment target in a high secure hospital? 
While these results may be disappointing, the use of CACR to target improvements in 
functional capacity may not be appropriate in a high secure forensic environment, due to 
patient characteristics as well as service related factors. 
 
One striking finding from this study is that the mean score on the measure of functional 
capacity for the ITTS very close to the threshold that would predict the ability to live 
independently within the community (Mausbach et al., 2008).  A further look at individual 
scores suggests that the majority of participants in the ITTS had a baseline functional 
capacity score above this threshold and that only two participants scored more than one 
standard deviation below.  Although it is possible that there are cultural differences in the 
threshold required for independent living, it is clearly important that interventions are 
formulation driven and responsive to individual need (Forensic Mental Health Matrix 
Working Group, 2011), and as such it should be established that individuals have a 










The opportunity to practice functional skills in a real-world setting has been noted to be a 
crucial bridge between functional capacity and real-world functioning (Holshausen et al., 
2014)  As such, high secure psychiatric clinics may be an inappropriate setting to target 
improvements in daily functioning, not only due to the lack of opportunities for practice but 
also due to the fact that many patients will move to lower levels of security before moving 
back to the community (Forensic Mental Health Matrix Working Group, 2011).  If CACR aims 
to improve functioning, it would make sense for CACR to be delivered in advance of a 
planned move the community, in conjunction with an intervention designed to directly help 
the development of functional skills which is thought to facilitate the generalisation of 
cognitive improvements (Gallagher, 2014). 
 
Despite these reservations, it is important to emphasise that CACR delivered in a forensic 
setting has possible benefits beyond improvements to functional capacity.  As mentioned in 
the introduction, CACR has the potential to contribute towards risk management 
(O’Rourke, 2013) and to improve outcomes of other psychological interventions (Ross & 
Hoaken, 2010), while the improvements to negative symptoms and self-esteem that were 
found in this study point to potential benefits for CACR that are unrelated to functional 
capacity.  It will be important for future research to be conducted into these alternative 
treatment targets for CACR in high secure setting. 
 
Recommendations 
The results of this study lead to a number of recommendations: 
1. Motivational deficits appear to be a problem common to both CR interventions and 
forensic interventions more generally.  The clinical implementation of CACR in high secure 
forensic settings should incorporate a range of appropriate motivation enhancing 
strategies. 
2. Future research should explore the role of CACR in high secure forensic settings for 








management.  Studies should also assess the hypothesised effect of motivational deficits on 
attrition, adherence and outcomes. 
3. Where CACR aims targets improvements to functional outcomes in a forensic population, 
it should be delivered at lower levels of security, when individuals have regular 
opportunities to practice functional skills in real-world settings.  It should also be delivered 
in conjunction with an intervention explicitly targeting the development of functional 
capacity.  A deficit in functional skills should be a criterion for treatment eligibility. 
 
Limitations 
Statistical power is limited by the small sample size, increasing the risk of Type II errors.  It is 
also possible that the risk of Type I errors was increased due to the number of comparisons 
made.  The reliability of outcome measures may have been undermined by a number of 
factors, including the omission of an assessment of inter-rater reliability and the failure to 
ensure assessors’ scores on CAINS training assessments were comparable to “gold 
standard” ratings.  The reliability of assessments over the course of the study was also not 
monitored and it is possible that the significant effects identified in the study reflect rater 
drift.  Assessors were not blinded, which may have affected outcomes, particularly those 
requiring significant clinical judgement such as the CAINS.  Reasons for attrition may differ 
between the research and service evaluation arms of the study, which was not explored.  
The intervention did not include a control group, therefore the significant effects found 
cannot be confidently attributed to CACR itself.  The use of LOCF may be an inappropriate 
way of dealing with missing data and can result in an overly conservative measure of 
effects.  The participants had a range of diagnoses therefore outcomes cannot be 
generalised to specific diagnostic categories.  This study does not cover neuropsychological 
outcomes which limits the ability to draw conclusions about the efficacy of CACR.  Despite 
the prominence of motivational issues within the CR and forensic literature, the effect of 









It should be noted that many of the limitations outlined above reflect the challenges and 
restrictions of the clinical setting and client group.  These challenges and restrictions are 
recognised as factors that have generally limited the development of evidence for 
psychological therapies delivered to forensic psychiatric patients (Forensic Mental Health 
Matrix Working Group, 2011). 
 
Conclusion 
Motivational deficits may have undermined the outcomes of this study and it will be 
important to ensure the delivery of CACR in forensic psychiatric settings is designed to 
incorporate strategies for enhancing motivation.  In addition, using CACR to target 
functional outcomes may be inappropriate within a high secure forensic setting.  As a 
result, the role of CACR as in managing risk and enhancing the outcomes of other 










Bowie, C. R., McGurk, S. R., Mausbach, B., Patterson, T. L., & Harvey, P. D. (2012). Combined 
cognitive remediation and functional skills training for schizophrenia: effects on 
cognition, functional competence, and real-world behavior. American Journal of 
Psychiatry, 169(7), 710–718. 
Belfrage, H. (1998). Implementing the HCR-20 scheme for risk assessment in a forensic 
psychiatric hospital: Integrating research and clinical practice. The Journal of Forensic 
Psychiatry, 9(2), 328–338. doi:10.1080/09585189808402200 
Bucci, P., Piegari, G., Mucci, A., Merlotti, E., Chieffi, M., De Riso, F., … Galderisi, S. (2013). 
Neurocognitive individualized training versus social skills individualized training: A 
randomized trial in patients with schizophrenia. Schizophrenia Research, 150(1), 69–
75. doi:10.1016/j.schres.2013.07.053 
Burton, C. Z., Vella, L., Harvey, P. D., Patterson, T. L., Heaton, R. K., & Twamley, E. W. (2013). 
Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia. 
Schizophrenia Research, 146(1-3), 244–248. doi:10.1016/j.schres.2013.02.026 
Butler, R. J., & Gasson, S. L. (2006). Development of the Self-Image Profile for Adults [SIP-
AD]. European Journal of Psychological Assessment, 22(1), 52–58. doi:10.1027/1015-
5759.22.1.52 
Byrne, L. K., Peng, D., McCabe, M., Mellor, D., Zhang, J., Zhang, T., … Xu, Y. (2013). Does 
practice make perfect? Results from a Chinese feasibility study of cognitive 
remediation in schizophrenia. Neuropsychological Rehabilitation, 23(4), 580–596. 
doi:10.1080/09602011.2013.799075 
Cohen, J. (1992). A power primer. Psychological Bulletin, 112(1), 155. 
D’ Amato, T., Bation, R., Cochet, A., Jalenques, I., Galland, F., Giraud-Baro, E., … Brunelin, J. 
(2011). A randomized, controlled trial of computer-assisted cognitive remediation for 
schizophrenia. Schizophrenia Research, 125(2-3), 284–290. 
doi:10.1016/j.schres.2010.10.023 
Dickinson, D., Tenhula, W., Morris, S., Brown, C., Peer, J., Spencer, K., … Bellack, A. (2010). A 
Randomized, Controlled Trial of Computer-Assisted Cognitive Remediation for 








Douglas, K. S., & Webster, C. D. (1999). The HCR-20 Violence Risk Assessment Scheme: 
Concurrent Validity in a Sample of Incarcerated Offenders. Criminal Justice and 
Behavior, 26, 3–19. 
Evans, C., Connell, J., Barkham, M., Margison, F., McGRATH, G., Mellor-Clark, J., & Audin, K. 
(2002). Towards a standardised brief outcome measure: psychometric properties and 
utility of the CORE—OM. The British Journal of Psychiatry, 180(1), 51–60. 
Fisher, M., Loewy, R., Carter, C., Lee, A., Ragland, J. D., Niendam, T., … Vinogradov, S. 
(2014). Neuroplasticity-Based Auditory Training Via Laptop Computer Improves 
Cognition in Young Individuals With Recent Onset Schizophrenia. Schizophrenia 
Bulletin. doi:10.1093/schbul/sbt232 
Forbes, C., Blanchard, J. J., Bennett, M., Horan, W. P., Kring, A., & Gur, R. (2010). Initial 
development and preliminary validation of a new negative symptom measure: The 
Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophrenia Research, 
124(1-3), 36–42. doi:10.1016/j.schres.2010.08.039 
Forensic Mental Health Matrix Working Group. (2011). The Forensic Mental Health Matrix – 
A Guide to Delivering Evidence Based Psychological Therapies in Forensic Mental 
Health Services in Scotland. Retrieved from 
http://www.forensicnetwork.scot.nhs.uk/forensic-matrix 
Gallagher, M. (2014). Improving Functional Outcomes in Schizophrenia with Computer 
Assisted Cognitive Remediation: A systematic review of effect sizes and methodology 
(Manuscript in Preparation). University of Edinburgh, Edinburgh, Scotland. 
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000). Neurocognitive deficits and 
functional outcome in schizophrenia. Schizophrenia Bulletin, 26(1), 119–136. 
Grynszpan, O., Perbal, S., Pelissolo, A., Fossati, P., Jouvent, R., Dubal, S., & Perez-Diaz, F. 
(2011). Efficacy and specificity of computer-assisted cognitive remediation in 
schizophrenia: a meta-analytical study. Psychological Medicine, 41(01), 163–173. 
doi:10.1017/S0033291710000607 
Harvey, P. D., Velligan, D. I., & Bellack, A. S. (2007). Performance-Based Measures of 
Functional Skills: Usefulness in Clinical Treatment Studies. Schizophrenia Bulletin, 
33(5), 1138–1148. doi:10.1093/schbul/sbm040 
Hert, M. D., Wampers, M., Thys, E., Wieselgren, I.-M., Lindström, E., & Peuskens, J. (2002). 








interscale validity and inter-rater reliability. International Journal of Psychiatry in 
Clinical Practice, 6(3), 135–140. 
Holshausen, K., Bowie, C. R., Mausbach, B. T., Patterson, T. L., & Harvey, P. D. (2014). 
Neurocognition, functional capacity, and functional outcomes: The cost of 
inexperience. Schizophrenia Research, 152(2-3), 430–434. 
doi:10.1016/j.schres.2013.08.004 
Horan, W. P., Kring, A. M., Gur, R. E., Reise, S. P., & Blanchard, J. J. (2011). Development and 
psychometric validation of the Clinical Assessment Interview for Negative Symptoms 
(CAINS). Schizophrenia Research, 132(2-3), 140–145. doi:10.1016/j.schres.2011.06.030 
López-Luengo, B., & Vázquez, C. (2003). Effects of Attention Process Training on cognitive 
functioning of schizophrenic patients. Psychiatry Research, 119(1-2), 41–53. 
doi:10.1016/S0165-1781(03)00102-1 
Mausbach, B. T., Bowie, C. R., Harvey, P. D., Twamley, E. W., Goldman, S. R., Jeste, D. V., & 
Patterson, T. L. (2008). Usefulness of the UCSD performance-based skills assessment 
(UPSA) for predicting residential independence in patients with chronic schizophrenia. 
Journal of Psychiatric Research, 42(4), 320–327. doi:10.1016/j.jpsychires.2006.12.008 
McGurk, S. R, Mueser, K. T., & Pascaris, A. (2005). Cognitive Training and Supported 
Employment for Persons With Severe Mental Illness: One-Year Results From a 
Randomized Controlled Trial. Schizophrenia Bulletin, 31(4), 898–909. 
doi:10.1093/schbul/sbi037 
McGurk, Susan R., Mueser, K. T., Covell, N. H., Cicerone, K. D., Drake, R. E., Silverstein, S. M., 
… Essock, S. M. (2013). Mental health system funding of cognitive enhancement 
interventions for schizophrenia: Summary and update of the New York Office of 
Mental Health expert panel and stakeholder meeting. Psychiatric Rehabilitation 
Journal, 36(3), 133–145. doi:10.1037/prj0000020 
Medalia, A., & Choi, J. (2009). Cognitive Remediation in Schizophrenia. Neuropsychology 
Review, 19(3), 353–364. doi:10.1007/s11065-009-9097-y 
Medalia, A., & Saperstein, A. M. (2013). Does cognitive remediation for schizophrenia 









Minzenberg, M. J., & Carter, C. S. (2012). Developing treatments for impaired cognition in 
schizophrenia. Trends in Cognitive Sciences, 16(1), 35–42. 
doi:10.1016/j.tics.2011.11.017 
NICE. (2009). Schizophrenia: core interventions in the treatment and management of 
schizophrenia in adults in primary and secondary. London: National Institute for Health 
and Clinical Excellence. 
Nuechterlein, K., Green, M., Kern, R., Baade, L., Barch, D., Cohen, J., … Marder, S.R. (2008). 
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and 
validity. American Journal of Psychiatry, 165(2), 203–213. 
O’Rourke, S. (2013). Risk assessment and management with clients with cognitive 
impairment. In Logan, C. & Johnstone, L. (eds.). Managing Clinical Risk: A guide to 
effective practice (pp. 183–198). Oxford: Routledge. 
Ogilvie, J. M., Stewart, A. L., Chan, R. C. K., & Shum, D. H. K. (2011). Neuropsychological 
Measures of Executive Function and Antisocial Behavior: A Meta-Analysis. Criminology, 
49(4), 1063–1107. doi:10.1111/j.1745-9125.2011.00252.x 
Olver, M. E., Stockdale, K. C., & Wormith, J. S. (2011). A meta-analysis of predictors of 
offender treatment attrition and its relationship to recidivism. Journal of Consulting 
and Clinical Psychology, 79(1), 6–21. doi:10.1037/a0022200 
Patterson, T. L., Goldman, S., McKibbin, C. L., Hughs, T., & Jeste, D. V. (2001). UCSD 
Performance-Based Skills Assessment: development of a new measure of everyday 
functioning for severely mentally ill adults. Schizophrenia Bulletin, 27(2), 235–245. 
Rocha, N. B. F., Marques, A. B., Fortuna, R. B., Antunes, A., & Hoaken, P. N. S. (2014). 
Effectiveness of cognitive remediation for female inmates: a pilot study. The Journal of 
Forensic Psychiatry & Psychology, 25(2), 224–237. doi:10.1080/14789949.2014.884617 
Ross, E. H., & Hoaken, P. N. S. (2010). Correctional remediation meets neuropsychological 
rehabilitation: How brain injury and schizophrenia research can improve offender 
programming. Criminal Justice and Behavior, 37(6), 656–677. 
Sanchez, P., Pena, J., Bengoetxea, E., Ojeda, N., Elizagarate, E., Ezcurra, J., & Gutierrez, M. 
(2014). Improvements in Negative Symptoms and Functional Outcome After a New 
Generation Cognitive Remediation Program: A Randomized Controlled Trial. 








Saperstein, A. M., & Kurtz, M. M. (2013). Current Trends in the Empirical Study of Cognitive 
Remediation for Schizophrenia.pdf. Candian Journal of Psychiatry, 58(6), 311–318. 
Schuhfried. (n.d.). CogniPlus. Retrieved from 
http://www.schuhfried.it/uploads/tx_schuhfriedprodukte/CogniPlus_en_Katalog_SCH
UHFRIED__3_39.pdf 
Thomson, L., Bogue, J., Humphreys, M., Owens, D., & Johnstone, E. (1997). The State 
Hospital survey: A description of psychiatric patients in conditions of special security in 
Scotland. The Journal of Forensic Psychiatry, 8(2), 263–284. 
doi:10.1080/09585189708412010 
Twamley, E. W., Burton, C. Z., & Vella, L. (2011). Compensatory cognitive training for 
psychosis: who benefits? who stays in treatment? Schizophrenia Bulletin, 37(suppl 2), 
S55–S62. 
Twamley, E. W., Vella, L., Burton, C. Z., Heaton, R. K., & Jeste, D. V. (2012). Compensatory 
Cognitive Training for Psychosis: Effects in a Randomized Controlled Trial. The Journal 
of Clinical Psychiatry, 73(09), 1212–1219. doi:10.4088/JCP.12m07686 
Van Stelle, K. R., Blumer, C., & Moberg, D. P. (2004). Treatment retention of dually 
diagnosed offenders in an institutional therapeutic community. Behavioral Sciences & 
the Law, 22(4), 585–597. doi:10.1002/bsl.602 
Webster, C. D., Douglas, K. S., Eaves, D., & Hart, S. D. (1997). HCR-20: Assessing Risk for 
Violence (Version 2). Burnaby, BC: Mental Health Law and Policy Unit, Simon Fraser 
University. 
Woods, P., Reed, V., & Robinson, D. (1999). The Behavioural Status Index: therapeutic 
assessment of risk, insight, communication and social skills. Journal of Psychiatric and 
Mental Health Nursing, 6, 79–90. 
Wormith, J. S., & Olver, M. E. (2002). Offender Treatment Attrition and its Relationship with 
Risk, Responsivity, and Recidivism. Criminal Justice and Behavior, 29(4), 447–471. 
doi:10.1177/0093854802029004006 
Wykes, T., Huddy, V., Cellard, C., McGurk, S. R., & Czobor, P. (2011). A Meta-Analysis of 
Cognitive Remediation for Schizophrenia: Methodology and Effect Sizes. American 



















Appendix 2.1 – Author guidelines for International Journal of Forensic 
Mental Health 
Instructions for authors 
  
This journal uses ScholarOne Manuscripts (previously Manuscript Central) to peer review manuscript 
submissions. Please read the guide for ScholarOne authors before making a submission. Complete 
guidelines for preparing and submitting your manuscript to this journal are provided below.  
Please note that the International Journal of Forensic Mental Health uses CrossCheck™  software to screen 
papers for unoriginal material. By submitting your paper to the International Journal of Forensic Mental 
Health you are agreeing to any necessary originality checks your paper may have to undergo during the 
peer review and production processes .  
 
 
Manuscript. International Journal of Forensic Mental Health receives all manuscript submissions 
electronically via their ScholarOne Manuscripts website located at:http://mc.manuscriptcentral.com/UFMH . 
ScholarOne Manuscripts allows for rapid submission of original and revised manuscripts, as well as 
faciliating the review process and internal communication between authors, editors and reviewers via a 
web-based platform. For ScholarOne Manuscripts technical support, you may contact them by e-mail or 
phone support viahttp://scholarone.com/services/support/ . If you have any other requests please contact 
the journal at rosenfeld@fordham.edu . 
  
Each manuscript must be accompanied by a statement that it has not been published elsewhere and that it 
has not been submitted simultaneously for publication elsewhere. Authors are responsible for obtaining 
permission to reproduce copyrighted material from other sources and are required to sign an agreement for 
the transfer of copyright to the publisher. As an author, you are required to secure permissions if you want 
to reproduce any figure, table, or extract from the text of another source. This applies to direct reproduction 
as well as "derivative reproduction" (where you have created a new figure or table which derives 
substantially from a copyrighted source). All accepted manuscripts, artwork, and photographs become the 
property of the publisher. 
  
All parts of the manuscript should be typewritten, double spaced, with margins of at least one inch on all 
sides. Number manuscript pages consecutively throughout the paper. Authors should also suppy a 
shortened version of the title suitable for the running head, not exceeding 50 character spaces. Each article 
should be summarized in an abstract of not more than 100 words. Avoid abbreviations, diagrams, and 
reference to the text in the abstract. Each author should be listed with his or her primary departmental 
affiliation and institution name, and city/state/country (where applicable). 
  
References. References, citations, and general style of manuscripts should be prepared in accordance with 
the APA Publication Manual, 6th ed. Cite in the text by author and date (Smith, 1983) and include an 
alphabetical list at the end of the article. Examples: Journal: Tsai, M., & Wagner, N.N. (1978). Therapy 
groups for women sexually molested as children. Archives of Sexual Behaviour , 7(6), 417-427. doi: 
10.1037/0096-3445.134.2.258 
Book: Millman, M. (1980). Such a pretty face. New York: W.W. Norton. 
Contribution to a Book: Hartley, J.T., & Walsh, D.A. (1980). Contemporary issues in adult development of 










Illustrations. Illustrations submitted (line drawings, halftones, photos, photomicrographs, etc.) should be 
clean originals or digital files. Digital files are recommended for highest quality reproduction and should 
follow these guidelines: 
 300 dpi or higher 
 Sized to fit on journal page 
 EPS, TIFF, or PSD format only 
 Submitted as separate files, not embedded in text files 
Color Illustrations. Color art will be reproduced in color in the online publication at no additional cost to 
the author. Color illustrations will also be considered for print publication; however, the author will be 
required to bear the full cost involved in color art reproduction. Color reprints can only be ordered if print 
reproduction costs are paid. Print Reproduction: $900 for the first page of color; $450 per page for the next 
three pages of color. A custom quote will be provided for articles with more than four pages of color. Art not 
supplied at a minimum of 300 dpi will not be considered for print. 
  
Tables and Figures. Tables and figures (illustrations) should not be embedded in the text, but should be 
included as separate sheets or files. A short descriptive title should appear above each table with a clear 
legend and any footnotes suitably identified below. All units must be included. Figures should be completely 
labeled, taking into account necessary size reduction. Captions should be typed, double-spaced, on a 
separate sheet. 
  
Proofs . Page proofs are sent to the designated author using Taylor & Francis' Central Article Tracking 
System (CATS). They must be carefully checked and returned within 48 hours of receipt. 
  
Reprints and Issues. Reprints of individual articles are available for order at the time authors review page 
proofs. A discount on reprints is available to authors who order before print publication. Each corresponding 
author will receive 1 complete issues in which the article publishes and a complimentary PDF. This file is for 
personal use only and may not be copied and disseminated in any form without prior written permission 
from Taylor and Francis Group, LLC.  
 
Authors for whom we receive a valid email address will be provided an opportunity to purchase 
reprints of individual articles, or copies of the  complete print issue.  These authors will also be given 
complimentary access to their final article on Taylor & Francis Online.   
  
Open Access 
Taylor & Francis Open Select provides authors or their research sponsors and funders with the option of 
paying a publishing fee and thereby making an article fully and permanently available for free online access 
– open access – immediately on publication to anyone, anywhere, at any time. This option is made available 
once an article has been accepted in peer review. Full details of our Open Access programme .  
  
Search Engine Optimization  
Search Engine Optimization (SEO) is a means of making your article more visible to anyone who might be 














Appendix 2.2 – HCR-20 




H1. Previous Violence 
Violence is defined as actual, attempted or threatened harm to a person or persons.   
It is behaviour which obviously is likely to cause harm to another person or persons.   
All sexual assaults should be considered violent  
Include criminal or civil sanctions i.e. all hospital admissions resulting from violence. 




RATING There is clear evidence that this risk factor is present 
There is sufficient evidence to suggest that this risk factor is 
partially present 
There is no evidence that this risk factor is present 
RATING This risk factor is clearly relevant to risk management 
This risk factor is partially relevant to risk management 
This risk factor is not relevant to risk management 
 
H2. Young Age at First Violent Incident 
Age categories: under 20; 20-39; 40+ 




RATING There is clear evidence that this risk factor is present 
There is sufficient evidence to suggest that this risk factor is 
partially present 
There is no evidence that this risk factor is present  
RATING This risk factor is clearly relevant to risk management 
This risk factor is partially relevant to risk management 
This risk factor is not relevant to risk management  
 
H3. Relationship instability 
This item applies only to “romantic” intimate or non-platonic partnerships and  
excludes relationships with friends and family 
Instability relates to many short-term relationships; absence of any relationships;  
presence of conflict within long-term relationships. 
SOURCE SUPPORTING INFORMATION 
  
 
RATING There is clear evidence that this risk factor is present 









There is no evidence that this risk factor is present  
RATING This risk factor is clearly relevant to risk management 
This risk factor is partially relevant to risk management 
This risk factor is not relevant to risk management  
 
H4. Employment problems 
This relates to individuals who refuse to seek legitimate employment, or have a history 
of having many jobs within short-term periods, or frequently being fired or quitting  
employment 
Note whether mental or physical disabilities were involved. 
SOURCE SUPPORTING INFORMATION 
  
 
RATING There is clear evidence that this risk factor is present 
There is sufficient evidence to suggest that this risk factor is 
partially present 
There is no evidence that this risk factor is present  
RATING This risk factor is clearly relevant to risk management 
This risk factor is partially relevant to risk management 
This risk factor is not relevant to risk management  
 
H5. Substance use problems 
Assessor is interested in whether there exists impairment of functioning in areas of  
health, employment, recreation, and interpersonal relationships, which is attributable  
to substances. Include neurological damage as a result of substance use.  Include  
misuse of prescription drugs, as well as solvents and glue. 





RATING There is clear evidence that this risk factor is present 
There is sufficient evidence to suggest that this risk factor is 
partially present 
There is no evidence that this risk factor is present  
RATING This risk factor is clearly relevant to risk management 
This risk factor is partially relevant to risk management 
This risk factor is not relevant to risk management  
 
H6. Major mental illness 
This item is scored on the basis of past history and is unaffected by whether the  
disorder is currently active or in remission. 
Include illnesses involving disturbances of thought and affect (e.g. psychotic illnesses, 
 manic mood illnesses, organic illnesses, learning difficulties).  Include even when  
diagnosis is unclear. 
SOURCE SUPPORTING INFORMATION 
  
RATING There is clear evidence that this risk factor is present 









There is no evidence that this risk factor is present  
RATING This risk factor is clearly relevant to risk management 
This risk factor is partially relevant to risk management 
This risk factor is not relevant to risk management  
 
H7. Psychopathy 
This item relates to the patients Psychopathy Checklist score 






RATING There is clear evidence that this risk factor is present 
There is sufficient evidence to suggest that this risk factor is 
partially present 
There is no evidence that this risk factor is present  
RATING This risk factor is clearly relevant to risk management 
This risk factor is partially relevant to risk management 
This risk factor is not relevant to risk management  
 
H8. Early Maladjustment 
This item taps maladjustment at home, school, or in the community before the age of  
17.  It includes two very different ways in which childhood maladjustment predicts  
later violence.  One way is through childhood victimization, the other through the  
child being a childhood victimizer or delinquent.   





RATING There is clear evidence that this risk factor is present 
There is sufficient evidence to suggest that this risk factor is 
partially present 
There is no evidence that this risk factor is present  
RATING This risk factor is clearly relevant to risk management 
This risk factor is partially relevant to risk management 
This risk factor is not relevant to risk management  
 
H9. Personality Disorder 
This item relates to a diagnosis of a personality disorder which should conform to an  
official nosological system such as DSM or ICD. This item is scored on the basis of  
past history and is unaffected by whether the disorder is currently active or in remission 




RATING There is clear evidence that this risk factor is present 
There is sufficient evidence to suggest that this risk factor is 
partially present 
There is no evidence that this risk factor is present  








This risk factor is partially relevant to risk management 
This risk factor is not relevant to risk management  
 
H10. Prior Supervision Failure 
This item is concerned with serious supervision failures while the individual was on  
parole, probation, or under the auspices of some correctional or mental health agency  
or institution. 
Include minor failures resulting in minor disciplinary action such as returning late  
whilst on pass, causing a disturbance, failing to take medication as prescribed, using 
drugs or alcohol while prohibited. 






RATING There is clear evidence that this risk factor is present 
There is sufficient evidence to suggest that this risk factor is 
partially present 
There is no evidence that this risk factor is present  
RATING This risk factor is clearly relevant to risk management 
This risk factor is partially relevant to risk management 




C1. Lack of Insight 
This item refers to the degree to which the assessee fails to acknowledge and  
comprehend his or her mental disorder, and its effect on others.   
SOURCE SUPPORTING INFORMATION 
  
RATING  There is clear evidence that this risk factor is present 
There is sufficient evidence to suggest that this risk factor is 
partially present 
There is no evidence that this risk factor is present  
RATING  This risk factor is clearly relevant to risk management 
This risk factor is partially relevant to risk management 
This risk factor is not relevant to risk management  
 
C2. Negative Attitudes 
Here the authors are referring to the kind of pro-criminal or antisocial attitudes that  
have some likelihood of eventuating in violence.  This does not refer to the occasional  
pessimistic or other such attitude, but to entrenched antisocial and negative attitudes  
and beliefs  




RATING  There is clear evidence that this risk factor is present 









There is no evidence that this risk factor is present  
RATING  This risk factor is clearly relevant to risk management 
This risk factor is partially relevant to risk management 
This risk factor is not relevant to risk management  
 
C3. Active Symptoms of Major Mental Illness 
Clinicians in the course of examinations will be attentive to positive and negative  
psychotic symptoms – should follow a classification system 






RATING  There is clear evidence that this risk factor is present 
There is sufficient evidence to suggest that this risk factor is 
partially present 
There is no evidence that this risk factor is present  
RATING  This risk factor is clearly relevant to risk management 
This risk factor is partially relevant to risk management 




Impulsivity refers to dramatic hour-to-hour, day-to-day, or week-to-week fluctuations  
in mood or general demeanour.  It pertains to the inability to remain composed and  
directed even when under pressure to act. The Impulsivity Checklist (ICL-20)  
advanced by Webster and Jackson (1997b) has been recommended. 
Include overreactions to imagined slights and disappointments. 
SOURCE SUPPORTING INFORMATION 
  
RATING  There is clear evidence that this risk factor is present 
There is sufficient evidence to suggest that this risk factor is 
partially present 
There is no evidence that this risk factor is present  
RATING  This risk factor is clearly relevant to risk management 
This risk factor is partially relevant to risk management 
This risk factor is not relevant to risk management  
 
C5. Unresponsive to Treatment 
It is vital to know if the individual has sought help and accepted it, rejected it out of   
hand, or agreed to it merely to ‘look good’ to a court, review board or authority. 
May refuse treatment, start then stop, or “sham” their way through treatment but fail 
to benefit from it.  Also include non-compliance with medication. 
SOURCE SUPPORTING INFORMATION 
  
RATING  There is clear evidence that this risk factor is present 
There is sufficient evidence to suggest that this risk factor is 
partially present 
There is no evidence that this risk factor is present  








This risk factor is partially relevant to risk management 
This risk factor is not relevant to risk management  
 
RISK MANAGEMENT ITEMS: 
 
R1. Plans Lack Feasibility 
This may be due to the fact that the community agencies are unwilling (due to  
patient’s behaviour) or unable (due to lack of resources) to provide assistance.  Alternatively, 
 the patient may have played no role in making plans or be uninvolved with peers or  
family.  Finally, family and peers may be unwilling or unable to provide help. 
Include involvement with family during stay in The State Hospital.   
Include communications with social work. 
SOURCE SUPPORTING INFORMATION 
  
RATING  There is clear evidence that this risk factor is present 
There is sufficient evidence to suggest that this risk factor is 
partially present 
There is no evidence that this risk factor is present  
RATING  This risk factor is clearly relevant to risk management 
This risk factor is partially relevant to risk management 
This risk factor is not relevant to risk management  
 
R2. Exposure to Destabilisers 
This is meant to refer to situations in which persons are exposed to hazardous  
conditions to which they are vulnerable and which may trigger violent episodes.   
‘Hazardous conditions’ are unique to individuals, but may include the presence of  
weapons, substances or some victim group.  It is also related to lack of professional  
support or inadequate professional supervision.  
 
SOURCE SUPPORTING INFORMATION 
  
RATING  There is clear evidence that this risk factor is present 
There is sufficient evidence to suggest that this risk factor is 
partially present 
There is no evidence that this risk factor is present  
RATING  This risk factor is clearly relevant to risk management 
This risk factor is partially relevant to risk management 
This risk factor is not relevant to risk management  
 
R3. Lack of personal support 
It is important to determine exactly what services will be available from whom, and to  
look beyond the ‘good intentions’ of relatives and friends (and to ensure that such  
persons are, in fact, not simply being ‘used’ in an attempt to secure release or other  
privileges). 
SOURCE SUPPORTING INFORMATION 
   
 
 








There is sufficient evidence to suggest that this risk factor is 
partially present 
There is no evidence that this risk factor is present  
RATING  This risk factor is clearly relevant to risk management 
This risk factor is partially relevant to risk management 
This risk factor is not relevant to risk management  
 
R4. Noncompliance with remediation attempts 
This is coupled with motivation to succeed and willingness to comply with medication 
and other therapeutic regimes.  Individuals who score high on this item may lack  
motivation to succeed and willingness to comply with medication and therapy, or  
refuse to follow rules.  Should be constructed broadly to include remediation attempts  
in both therapeutic and supervision/management realms.   
SOURCE SUPPORTING INFORMATION 
  
RATING  There is clear evidence that this risk factor is present 
There is sufficient evidence to suggest that this risk factor is 
partially present 
There is no evidence that this risk factor is present  
RATING  This risk factor is clearly relevant to risk management 
This risk factor is partially relevant to risk management 
This risk factor is not relevant to risk management  
 
R5. Stress 
This part of the assessment entails trying to forecast what sources of stress the 
 individual is likely to encounter, and how she or he may react to or cope with these.  
 Suggested attention paid to three general areas: family, peer and employment 
SOURCE SUPPORTING INFORMATION 
  
RATING  There is clear evidence that this risk factor is present 
There is sufficient evidence to suggest that this risk factor is 
partially present 
There is no evidence that this risk factor is present  
RATING  This risk factor is clearly relevant to risk management 
This risk factor is partially relevant to risk management 






























































































































































Appendix 2.6 – Modified version of the UPSA 
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UCSD Performance-Based Skills Assessment 
(UPSA-2-VIM) 
Description 
The UCSD Performance-Based Skills Assessment (UPSA-2) is a role-play test 
designed to evaluate a person’s functional capacity in five selected domains of basic 
living skills. These areas include Financial Skills, Communication, 
Organisation/Planning, Transportation, and Household Management. Patients being 
tested utilise props to demonstrate how they perform everyday activities and are 
assessed on their actual performance. 
This version of the UPSA-2 begins with the Finance domain, which tests the 
patient’s ability to count money, give change and pay bills. In the first part of this 
task patients are provided with currency consisting of real coins (1 twenty pence, 4 
ten pence pieces, 6 five pence pieces, 8 pennies) (£1.03 total) and reproductions of 
paper bills (3 one pound notes, 1 five-pound note, and 1 ten-pound note). Patients are 
asked to count out given amounts of money (e.g., £1.02, £6.73, £12.49), and also 
give change from ten pounds. In the second part of the task patients are shown a bill 
from Scottish Power and asked questions to evaluate their understanding of the 
information included in the bill, e.g., who to pay, how much to pay, when to pay, etc. 
These tasks take about five minutes to complete and yield scores ranging from 0 to 
11. 
The next domain tested is Communication. Patients are provided with an unplugged 
telephone and asked to role-play a number of scenarios, e.g., what number to dial in 
case of an emergency, calling directory enquiries to obtain a telephone number, and 
then dialling that number from memory. Patients are also requested to read a letter 
scheduling a medical appointment and then role-play calling the doctor’s office to 
reschedule the appointment. In addition, patients are asked to describe how the letter 
requested them to prepare for the medical appointment (i.e., fast before giving a 
blood sample) and what two items they need to bring with them to the doctor (i.e., 
appointment letter and list of medications). These tasks require about five minutes to 









In the Organisation/Planning domain, patients are asked to read a “newspaper 
article” describing the opening of a new Water Theme Park. Patients are then 
asked a few questions to evaluate their comprehension of the material and 
requested to list seven items they think are necessary to bring or wear in order to 
spend the whole day at the Water Park. Points are given for answers deemed 
appropriate, e.g., swimsuit, towel, sunscreen, jacket, umbrella, money, etc. This 
part of the assessment takes about five minutes to complete and yields scores 
ranging from 0 to 14. 
 
The Transportation domain tests the use of public transportation. In the first part 
of this section patients are provided with bus timetable showing the routes for 3 
different buses. Questions include which bus to ride to a specific destination, cost 
of the fare, finding the telephone number for trip planning and timetable 
information, where they would get off the bus to transfer to another bus and the 
location of two bus stops identified on the map. The second part of this 
section requires the individual to use the information from a bus route schedule to 
answer questions about when to catch a bus in order to arrive in time for an 
appointment, length of waiting time for the arrival of the bus and destination 
arrival time. These last three questions are timed for one minute apiece. This task 
requires about five minutes to complete and yields scores ranging from 0 to 9. 
 
In the Household Management domain, patients are provided with a recipe for 
rice dessert. They are then presented with an array of items that one might possibly 
have on hand in their pantry, e.g., pasta, jelly, cereal, soup, rice, canned tuna, 
toothpaste, canned vegetables, crackers, etc. individuals are requested to read the 
recipe, check the pantry, and then prepare a list of the items missing from the 
pantry that they need to buy in order to make the rice dessert. Points are given for 
each correct item on the shopping list. This task is timed for five minutes and 









ADMINISTRATION & SCORING 
1. Instructions for each task may be given only once unless otherwise stated. 
Instructions may be repeated only when it is clear that the subject has not heard 
the instructions correctly or does not understand the test instructions. 
 
2. If a task is incorrectly performed, it is scored as incorrect. The tester should not 
provide a new trial for that task. 
 
3. A spontaneous incorrect response after a correct response is scored as incorrect. 
 
4. The tester should move from task to task throughout the test without giving the 
subject feedback about whether the responses are correct or incorrect. 
 
5. In this manual, all information written in standard text are instructions to the 
tester. Below the instructions are text boxes. Text in these boxes in bold Arial 
type are prompts to be spoken to the subject, and text in non-bold Arial type 
are acceptable answers to questions and should not be read to the patients. 
 
EQUIPMENT 
1. Role-play Cards: 
√ Water Theme Park    √ Route Maps for Buses:  
√ Scottish Power Gas & Electric Bill     #22, #46, & #8 





1 ten-pound note, 1 five-pound note, 3 one-pound coins (play money) 
1 twenty pence piece, 4 ten pence pieces, 7 five pence pieces, 8 pennies (real coins) 
(£1.03 total change) 
 
4. Push-Button Telephone with large push-button pads on telephone base 
 
5. 29 Pantry Items & Placement Diagram 
 
6. Shopping List worksheet 
 
7. UPSA Scoring Form 
 















1A. FINANCIAL SKILLS: 
COUNTING MONEY & GIVING CHANGE 
Props 
√ 1 ten pound note * 
√ 3 one pound coins * 
√ 1 five pound note * 
√ 1 twenty pence piece 
√ 4 ten pence pieces 
√ 7 five pence pieces 
√ 8 pennies 
* May substitute “play” money as long as it is a good facsimile of real money. 
Use only real coins. 
Procedure 
1. Lay out the paper currency in front of the subject from tester’s left to right as 
shown above. The coins may be placed together in a group to the left of the £5 
note. After the completion of each part of this task, the currency needs to be 
replaced in its original position. 
 
2. Give the subject the following instructions: (If necessary, instructions may be 
repeated but not more than twice). 
 
 
NOTE TO TESTER: If the subject first counts out £1.02 using a pound coin, 
the tester should repeat the instruction to use ONLY coins below the value of £1. If 






Show me six pounds and seventy-three pence. £6.73 
Show me twelve pounds and forty-nine pence. £12.49 
Imagine that you are buying some items from a store. You 
give me, the cashier, ten pounds to pay the bill. (Tester 
takes ten-pound bill from the currency laid out in front of 
subject). The items cost £6.27. Show me how much change 
you should get back from £10.00. 
£3.73 
NOTE TO TESTER: The subject may NOT calculate how much change 
he/she should receive using pen and paper or a calculator. 
Scoring & Timing 
One point is given for each correct answer and 0 points for incorrect answers. 
The tasks I’m now going to ask you to demonstrate include various kinds of everyday 
activities. I’ll tell you what to do and then I would like you to show me how you would 
actually do these tasks using the props I’ll give you. 
 
£5 £1 £1 £1 £10 










This task yields scores ranging from 0 to 4 and should take about two minutes to 
complete. 
1B. FINANCIAL SKILLS: PAYING BILLS 
Props 
√ Role-play Card – Scottish Power Gas & Electricity Bill 
 
Procedure 
1. Show the subject the bill from Scottish Power and say: 
 
PROMPT:   Correct Answer: 
 
Imagine that you received this bill 
from the utility company.  
What is the name of the company you 
need to pay? 
 
Scottish Power 
How much do you need to pay? Eighty-four pounds and eighteen 
pence (£84.18) 
How much are the current charges? Forty-four pounds and thirty-four 
cents (£44.34) 
 
Why is the new balance more than the 
current charges? 
 
The bill for the previous month was 
not paid. 
 
When do you need to pay this bill? Before 27
th
 October 
What is the account number? 8497936006 
What telephone number can you call 
if you have questions about your bill? 
 
0845 2700 700 or 0845 027 4500 
 
 
NOTE TO TESTER: Do not take away or conceal the utility bill. This is not a 
memory task. Give credit to any variation of the above answers if it is reasonable. 
 
Scoring & Timing 
One point is assigned for each correct item and 0 points for incorrect answers. This 










2. COMMUNICATION SKILLS: TELEPHONE & LETTER 
Props 
√ Role-play Card - Medical Doctor Appointment Letter 
Note: The date for the medical appointment should be at least one to two 
months ahead of the subject’s testing date. The date in the letter will need to be 
changed regularly. Choose the first Monday of the month or the second Monday 
if the first falls on a holiday. 
 
√ Push-button telephone (disconnected). Make sure that the number keypad is 
located on the telephone base and NOT on the handset. Also, if possible, choose 
the model of telephone where the handset needs to be picked up in order to 
access the dialing pads. 
 
Procedure 
This task requires that the subject demonstrate that he/she knows how to use a 
telephone. This includes picking up the receiver, pushing the buttons for numbers, 
and speaking into the mouthpiece. The subject should put the receiver back and 
repeat this sequence for each task listed below. With the exception of dialing from 
memory, instructions are given only once. 
 
1. Place the telephone in front of the subject and give the following instructions: 
 
We’re going to use this telephone for 
the next tasks. Even though it’s 
disconnected, show me everything 
you normally do when using a 
telephone. 
First, show me what number you 
would dial for help in case of an 
emergency. 
 
Answer: (dial) 999 
 
 
2. Instruct the subject to do the following: 
 
Please call directory enquiries and 
ask for the telephone number of 









3. Instruct the subject to do the following: 
 
Listen carefully to this number and dial it from memory: 596-6996 
 
NOTE TO TESTER: The number needs to be dialed from memory but may be 
repeated at 








examiner may present the whole number again. The subject can dial the remaining 
numbers 
in order or can hang up and dial the whole number. If the subject requests the 
examiner to 
repeat the number a third time, the examiner should tell the subject to dial whatever 
he/she 
remembers. 
(continues on next page) 
 
 
4. Instruct the subject to read the Medical Appointment letter by saying: 
Imagine that this is a letter from your Doctor. Please read the letter 
out loud. Read it carefully because I will ask you some questions 
about it. 
 
5. After the subject is finished reading, give the following instructions: (Do not 
remove or conceal the Medical Appointment letter from the subject). 
 
Call the doctor’s office and leave a voice-mail message requesting 
to reschedule your medical appointment for the following day at the 
same time. Be sure to include all necessary information. 
 
 
NOTE TO TESTER: The subject needs to find the telephone number for 
rescheduling 
appointments listed in the letter (0141) 324-5612 and dial the number correctly (1 
point), 
give his/her name (1 point), the date of the current appointment (MONDAY 1
st
 
OCTOBER  [or month & date written in letter] at 8 a.m.) (1 point) and ask to 
reschedule the appointment for the following day at the same time (TUESDAY 2nd 
OCTOBER [or month & date following date written in letter] at 8 a.m.) (1point), and 
leave a callback telephone number (1 point) (5 points total). 
 
6. Remove or conceal the role-play card and ask the following: 
 
What are the two items listed in the letter 
that you need to bring with you 
to the medical appointment? 
 
Answers: 
This appointment letter 
List of current medications (Also 
accept: “My medications”) 
 
 
7. Ask the following question: 
 
What else did the letter ask you to do 
to prepare for the doctor’s 
appointment? 
Answer: 
No food or liquids except water for 











Scoring & Timing 
One point is given for each correct answer and 0 points for incorrect answers. This 











3. COMPREHENSION & PLANNING: WATER THEME PARK 
Props 
√ Role-play Card: Newspaper article on “Opening of New Water Theme Park” 
√ Magnifier (if necessary) 
Procedure 
1. Show the subject the first role-play card (Water Theme Park) and give the 
following instructions: 
 
Please read this article about the opening of a new Water Theme Park out 
loud. Read it carefully because I will ask you some questions about it. 
 
 
2. When the subject finishes reading the story, remove or conceal the role-play 
card and ask the following questions: 
PROMPT: Answer: 
According to the story you just read, 




When does the Water Park open? 10 a.m. 
 
When does the Water Park close? 9 p.m. 
 
Tell me four activities you could do at the 
Water Park. 
 
Acceptable answers: wave pool, 
inflatable boat, body slides, roller 
coaster, Ferris wheel, water wars, bumper 
car derby, go-kart races, eat at the BBQ 
 
Imagine that you are going to the Water 
Park to spend the day. There 
might be many things you’d like to take 
with you but tell me SEVEN 
things you REALLY NEED to wear or 
bring with you in order to spend the 
whole day there? 
 
Acceptable answers: bathing suit or swim 
trunks, sunscreen, towel, water/drinks, 
change of clothes, money, jacket or 
sweater, raincoat, umbrella, medications,  
Camera, Beach ball/Fins, Tote 
bag/Backpack, Snacks, Bus Pass, I.D, 
Water goggles, Shoes & socks, Rain 
boots/boots, Shorts, Sandals/Flip-Flops, 
Sunglasses Sun hat 
 
 
(One answer, at least, must reflect the 
fact that the day will turn cold and rainy). 
NOTE TO TESTER: 
See Appendix A for further examples of appropriate and inappropriate answers 
for things to bring or wear to the Water Theme Park. 
Scoring & Timing 
One point is given for each correct answer and 0 points for incorrect answers. This 
















4. TRANSPORTATION: BUS TIMETABLES 
 
Props 




1. Place the three bus timetables side-by-side in front of the subject from tester’s 
left to right ( #22, #8, #46) and ask the following questions: 
 
Looking at these bus schedules, tell me 
which bus you would take to go to the 







2. Remove the bus schedules for #8 and #46 and ask the following questions 
pertaining to bus schedule #22 only. 
 
PROMPT: Answer: 
How much is your bus fare for one 
journey? 
 
£2.00 for basic normal or £1.00 
for senior citizen/disabled 
What telephone number would you call 




Look at the map for Route #22. 
 
Point to the two bus stations. 
 
Mulberry Lane & Grape Street 
 
Point to the place where you would 
transfer to route 54. 
 




3. Turn over bus schedule #22. Show the subject the schedule on the back and 




Look carefully at this schedule for bus 
#22. It shows the places where you can 
get on and off the bus and the times the 
bus will arrive at those places. Use this 
schedule to answer the next questions. 
Imagine that you get off the Mulberry 
Lane Bus station on Wednesday morning 
at 9:00 (PAUSE). You want to catch the 










(PAUSE). How long will you wait before 
the bus arrives? 
 
What time will you get to Grand Avenue? 9:41 a.m. 
 
 
(continues over page) 
 
 
Imagine that you have an appointment 
with your doctor at the Central Hospital 
for next Monday at 9:20 a.m. (PAUSE). 
You live on Grand Avenue next to the 
Grand Airport (PAUSE). What is the latest 
time you can catch the bus in order to 










NOTE TO TESTER: 
The above three questions using the route schedule for bus #22 are timed. 
Allow the subject up to one minute to answer each question before 
proceeding to the next. The questions may be read twice if needed. 
 
Scoring and Timing 
For each of the above questions, one point is given for each correct answer and 0 
points for incorrect answers. This task yields scores ranging from 0 to 9 and should 









5. HOUSEHOLD MANAGEMENT: SHOPPING LIST 
Props 
√ Role-play Card: – Recipe for Rice Dessert 
√ Simulated Pantry (See Appendix B for list of grocery items). Set up the 
pantry items according to the diagram found in Appendix C. The items 
should be concealed from the subject’s view, however possible, until the 
tester reveals the contents of the pantry for this task. 




1. Show the subject role-play card for the rice dessert recipe and instruct the 
subject as follows: 
 
Our next task involves household skills. Look at this recipe for rice dessert. Here is 
the list of ingredients that you need to make the dessert. 
(Point to the list of ingredients). 
 
 
2. Reveal the contents of the pantry to the subject. Give the shopping list and pen 
to the subject and give the following instructions: 
 
Imagine that this is your pantry at home. 
Look at the list of ingredients that you 
need for the recipe and check the pantry 
to see what items you already have and 
what 
items are missing. Please write down all 
the missing items on this shopping list so 




Sugar, Raisins, Cinnamon, Cloves 
 
 
3. Set the timer for five minutes and remove the shopping list when the timer 
rings. 
 
NOTE TO TESTER: If the list contains more than four items, scoring is based on 
the 
FIRST FOUR ITEMS ONLY. One point is given for each correct answer and 0 
points for 
incorrect answers. This task yields scores of 0 to 4. Since this is a timed task, it 
should take 
five minutes or less to complete. 
 
4. After the role-play has ended, if the subject asks about his/her performance, the 










You listened carefully to the directions and tried very hard. Good job. 
 
APPENDIX A 
Scoring Examples for Water Theme Park Story   
 
Bathing suit  1      Bus Pass   1 
Sunscreen   1      Shorts    1 
Towel    1      Sandals/Flip-Flops 1 
Sun hat  1      Raincoat   1 
Sun umbrella   1     Jacket    1 
Snacks   1     Sweater   1 
Water/Drinks   1     Rain boots/boots  1 
Change of clothes  1      Umbrella   1 
Money   1      Shoes & socks  1 
Tote bag/Backpack 1      Water goggles  1 
Medications   1      Sunglasses   1 
Beach ball/Fins 1      I.D.    1 
Camera   1 
Ski boat   0 
Stove to cook lunch  0 
Beer    0 
Twinkies   0 
New outfit   0 
Mayonnaise   0 
Baloney   0 
Life preserver rope  0 
 
These scores are a suggested rubric since each situation will be unique. In order to 
assign scores to answers, the examiner should rely on the following criteria: 
 
1 = an item to bring or wear to the Water Theme Park which is really needed in 
order to spend the whole day there comfortably. 
 
0 = an item which is illogical/unacceptable/unreasonable/illegal/etc. 
 
Please consult with the authors in the event of specific scoring items and issues 













1 Uncle Ben’s Long Grain Rice 
2 SAXA fine sea salt 
3 Tesco pineapple pieces 
4 Kellogg’s Corn Flakes 
5 Heinz Tomato ketchup 
6 Tesco milk 
7 Princes Tuna Steak 
8 Sponges 
9 7-up (2 litres) 
10 Bachelor’s dried peas 
11 Kleenex tissues 
12 Hartley’s strawberry jelly 
13 ASDA mini corn cobs 
14 Marshall’s macaroni 
15 Hellman’s French dressing 
16 Egg carton 
17 KP honey roast peanuts 
18 Rakusen’s Crackers 
19 Hartley’s strawberry jam 
20 Tesco Orange Juice 
21 Laundry detergent 
22 Bachelor’s Cup-a-Soup 
23 Flora margarine 
24 Tesco mint humbugs 
25 Colgate toothpaste 
26 Coca Cola (500ml) 
27 Nutmeg 
28 Walker’s Ready Salted 















Orange juice ◊ 7-Up ◊Milk ◊ Crackers ◊ Cereal ◊ Ketchup 
 
Crisps ◊Sponges ◊ Salt ◊ Salad Dressing ◊Jelly ◊ Detergent 
 
Peanuts ◊ Coca Cola ◊ Soup ◊Corn ◊ Mint sweets ◊ Eggs 
 
Margarine ◊ Jam ◊ Peas ◊Kleenex 
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   Baseline Allowance 18 Therms 
Baseline 18 Therms @ £.62672 16/33 Days 
           Non-Baseline 2 Therms @ £.83920 16/33 Days 
Baseline 18 Therms @ £.65271 17/33 Days 
-Baseline 2 Therms @ £.86519 17/33 Days 
SDG&E’s Average Cost Per Therm This month £20642 
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    Baseline Allowance 274 kWh 
        Baseline Usage 274 kWh @ £.10438 
  Non-Baseline Usage 15 kWh @ £.12470 
Legislated 10% Reduction -3.05 
             Total Electricity Charges £27.42 
 
 
The Total Electricity Charges shown above include the following components. 
            Please see definitions on back of bill. 
 
 
Electric Energy (£.042837/kWh)............   12.38 
Transmission ......................................     2.33 
Distribution ........................................   12.64 
Public Purpose Programs ......................    1.13 
Nuclear Decommissioning.....................       .58 
Trust Transfer Amount ........................  . 4.60 
Competition Transition Charge ........  –6.24 
Total Electricity Costs...........................  27.42 
 
Email: Info@scottishpower.com Questions? Please Call: 0845 2700 700 or 0845 027 4500 








Billing Days 33 
 






This Month        
Percentage 
Last Year          Change 
0.4                     +42.9% 





Please return this portion with your payment. 






















Make Payment To: 
Scottish Power plc PO Box 1839, Glasgow, G9 8XB      Please write your account number on 








MOTHERWELL CENTRAL MEDICAL 
GROUP 








This letter is to remind you of your upcoming annual check up. Your appointment 
with: 
 
DR. JAMES HUTCHIN 
MOTHERWELL CENTRAL MEDICAL GROUP 
101 FIRST AVE 
MOTHERWELL 
 
has been scheduled for: 
 






YOU ARE SCHEDULED TO GIVE A BLOOD SAMPLE AT THIS APPOINTMENT. 
DO NOT EAT ANY FOOD OR DRINK LIQUIDS EXCEPT WATER FOR THE 
12-HOUR PERIOD BEFORE YOUR APPOINTMENT. 
 
PLEASE REMEMBER TO BRING WITH YOU THE FOLLOWING: 
1) THIS APPOINTMENT LETTER 
2) LIST OF CURRENT MEDICATIONS 
 
TO RESCHEDULE, OR FOR ANY QUESTIONS REGARDING YOUR 






JAMES HUTCHIN, M.R.C.G.P. 










When you picked up the local newspaper this morning, this front-page headline 
struck your eye: 
 
GRAND OPENING OF NEW WATER PARK! 
 
Wild Water is the country’s newest and largest water theme park with over 40 acres 
of water thrills for all ages. Come and surf the waves in the heated million-gallon 
wave pool. Then float down the “Rio River” in an inflatable boat. Thrill-seekers 
may try the heart-pounding twists and turns in the 5-story body slides and plunge 
down 200 feet on the water flume rides. For the land lubbers, there’s the thrilling 
all-wooden roller coaster and the largest Ferris Wheel in the country. 
 
To celebrate the Grand Opening, free special events will take place. Family Fun 
Day begins at 10 a.m. with a number of fun events including Water Wars, Bumper 
Car Water Derby, and Go-karting Races. Many great prizes will be awarded. 
Included in the admission price is a delicious barbecue featuring hot dogs, chips, 
Ice creams, and soft drinks. 
 
Wild Water Theme Park is open 7 days a week from 10 a.m. to 9 p.m. Admission 
to the Family Fun Day is £5.00 (£3.00 Disabled) including all events and food. 
Since there is no bus service to the Park and parking is expensive, we 
recommend taking the free shuttle service. Shuttles run from midtown to the 
park every 15 minutes. For more information call (0141) 815-3958. 
 
The Grand Opening is tomorrow and you want to spend the whole day at the Water 
Park. The weather report predicts a hot sunny day with a high temperature of 95 
degrees. However, at sundown the temperature will drop quickly to a cool and 
windy 55 degrees with an 80% chance of rain. You decide to spend the whole day, from 












      
1 1/2 cups Uncle Ben’s converted white rice 
1 cup milk 
2 eggs 
2 tablespoons margarine 
1/3 cup sugar, or more or less to taste 
3/4 cup raisins 
2 teaspoons vanilla extract 
1 teaspoon cinnamon 
1/4 teaspoon each ground nutmeg and ground cloves 
 
 
Cook the rice as directed on the package. When it is done, 
pre-heat the oven to 325 degrees F. 
 
Combine the cooked rice in a mixing bowl with the 
remaining ingredients. Mix thoroughly and pour the 
mixture into an oiled large shallow baking dish. Cover with 
a lid or foil and bake for 30 minutes. Then uncover and 










    




UCSD PERFORMANCE-BASED SKILLS 
ASSESSMENT SCORING FORM (UPSA-2) 
 
 
SCORE:   RESPONSE: 
 
1A. FINANCIAL SKILLS:    Correct (1 point) 
Counting and Giving Change   Incorrect (0 points) 
 
 
£1.02 (in coins)     _____________ 
 _____________ 
 
£6.73       _____________  
 _____________ 
 
£12.49      _____________  
 _____________ 
 




1B. FINANCIAL SKILLS:     Correct (1 point) 









Company:      _____________ 
 _____________ 
 
Payment due:      _____________ 
 _____________ 
 
Current charges:     _____________ 
 _____________ 
 
New balance:      _____________ 
 _____________ 
 
Due date:      _____________ 
 _____________ 
 
Account number:     _____________ 
 _____________ 
 





2. COMMUNICATION SKILLS:    Correct (1 point) 
Incorrect (0 points) 
 
Dial Emergency #:     _____________ 
 _____________    
Dial Directory Assistance:    _____________ 
 _____________     
Appropriate Inquiry:     _____________ 
 _____________    
Dial # from Memory:    _____________ 
 _____________     
Correct (1 point)  
Incorrect (0 points) 
 
Dial # from Letter:     _____________ 
 _____________ 
 
Patient name:      _____________ 
 _____________ 
 










Suggested appointment date    _____________ 
 _____________ 
 
Return Telephone number:    _____________ 
 _____________ 
 
Appointment letter:                     _____________ 
 _____________ 
 
Medication List:     _____________ 
 _____________ 
 
Fast for Giving Blood Sample:   _____________ 
 _____________ 
 
3. COMPREHENSION/PLANNING:  Correct (1 point) 
Incorrect (0 points) 
Water Park Scenario 
 
How to arrive:     _____________ 
 _____________ 
 
Time open:      _____________ 
 _____________ 
 










SCORE:   RESPONSE: 
Correct (1 point) 
Incorrect (0 points) 
 
What to do:      _____________ 
 _____________ 
 
_____________  _____________ 
 
_____________  _____________ 
 
_____________  _____________ 
 
 
Appropriate Items:     _____________ 
 _____________ 
 
_____________  _____________ 
_____________  _____________ 
_____________  _____________ 
_____________  _____________ 
_____________  _____________ 








4. TRANSPORTATION:    Correct (1 point) 
Incorrect (0 points) 
 
Bus to Grand Airport:    _____________ 
 _____________ 
 
Bus Fare:      _____________ 
 _____________ 
 
Bus Schedule Information:    _____________ 
 _____________ 
 
Bus Station#1:     _____________ 
 _____________ 
 




SCORE:    RESPONSE: 
Correct (1 point) 
Incorrect (0 points) 
Transfer to Bus #54:   _____________  _____________
   
Waiting time:     _____________  _____________ 
 
Time at destination:    _____________  _____________ 
 




5. HOUSEHOLD MANAGEMENT:  Correct (1 point) 
Incorrect (0 points) 
 
Sugar       _____________  _____________ 
 
Raisins      _____________  _____________ 
 
Cinnamon      _____________  _____________ 
 







































Fares and Schedules Subject to Change 
 
FARES – Exact fare, please 
 
Basic £2.00 
Senior Citizen/Disabled £1.00 




(11 tokens for the price of ten) 
Tokens are good for fare only on buses 
 
Monthly Ready Pass £54.00 
Senior Citizen/Disabled £13.50 
Youths (18 and under) £26.00 
 
(ID may be requested) 
@ Discounted passes made possible by Transnet 
 
 When transferring to a route with a higher cash fare of 
monthly pass then originally paid, an upgrade for the 
difference is required. Upgrades may be paid on the 
original or connecting vehicle. Senior Citizen/Disabled 
passengers pay no upgrades. 
Take advantage of Two Special Offers for Friends and Family! 
 
Family Weekends – Two children (12 years old and under) travel for 
free with all adult (18+) fare paying passengers every weekend. 
 
Friends travel for free on selected holidays when one person pays by 
cash, ticket or token or uses a Ready Pass, a friend gets the same full 
journey free. Look out for Friends Travel for Free on New Years Day, 
Public Holidays and Christmas. 
INFORMATION: for trip planning and other information 0141-242-
3456; (TTY/TDD for hearing impaired, 0141-323-7890); InfoExpress, 
24-hour departure information via touch time phone, 0141-798-
3223. MTS Online: www.buscommute.com. 
REGIONAL TRANSFER POLICY 
A transfer slip is issued only when fare is paid. It is good until the 
date and time shown (App. 90 minutes from the last time point). 
Round trips may be made during this time. A transfer may be used to 
connect to any regular MTS bus, tram, coach and train connection. 
Upgrades may be required. 
SENIOR CITIZEN/DISABLED PASSENGERS: must show proof of 
elgibility (driving licence, DVLA Senior Citizen/Disabled card, pension 
or concessions cards upon request. 
FAREBOXES: accept £1 notes, coins but do not give change. 
PRIORITY SEATING: at the request of the driver, please reserve the 
seats at the front of the bus for Senior citizens and the Disabled. 
ANIMALS: Trained guide dogs my accompany persons with 
disabilities. Other animals must be in an enclosed carrier and 
transported without assistance by the driver or operator. The carrier 
must be places on the passenger’s lap or under a seat. 
THE TRANSIT STORE: 102 Broadway at 1st street, 234-1060 
(weekdays 8:30AM-5:30PM, weekends Noon- 4:00PM). Passes, 
tickets, tokens, schedules, lost & found, ID cards 9weekdays 9:00AM-
4:30Pm, weekends Noon to 3:00PM). Closed Holidays. 
 
HOW TO USE THE BIKE BUS 
When preparing to board a bike bus, make certain the driver knows 
you want to place your bike in the rack which is located at the front 
of the bus. Place both wheels of the bike in an upright position in the 
rack provided. Secure your bike in place. There is no charge for use 
of the bike rack. When removing your bike from the bike rack, again, 
make certain the driver knows you wish to remove your bike. 
Metropolitan Transit does not assume any responsibility for 
improper loading or use of the bike rack. 
 
The schedules and other arrangements shown in the timetable are 
subject to change. Metropolitan Transit does not assume 
responsibility for errors in timetables, nor for any inconvenience 
 
Mulberry Ln. Bus Station 
Grape St. Bus Station 
 
 
September 1, 2011 
 
All buses are provided with bike racks 
























   
ROUTE 8 
FARE INFORMATION 
Fares and Schedules Subject to Change 
 
FARES – Exact fare, please 
 
Basic £2.00 
Senior Citizen/Disabled £1.00 




(11 tokens for the price of ten) 
Tokens are good for fare only on buses 
 
Monthly Ready Pass £54.00 
Senior Citizen/Disabled £13.50 
Youths (18 and under) £26.00 
 
(ID may be requested) 
@ Discounted passes made possible by Transnet 
 
 When transferring to a route with a higher cash fare of 
monthly pass then originally paid, an upgrade for the 
difference is required. Upgrades may be paid on the 
original or connecting vehicle. Senior Citizen/Disabled 
passengers pay no upgrades. 
Take advantage of Two Special Offers for Friends and Family! 
 
Family Weekends – Two children (12 years old and under) travel for 
free with all adult (18+) fare paying passengers every weekend. 
 
Friends travel for free on selected holidays when one person pays by 
cash, ticket or token or uses a Ready Pass, a friend gets the same full 
journey free. Look out for Friends Travel for Free on New Years Day, 
Public Holidays and Christmas. 
INFORMATION: for trip planning and other information 0141-242-
3456; (TTY/TDD for hearing impaired, 0141-323-7890); InfoExpress, 
24-hour departure information via touch time phone, 0141-798-
3223. MTS Online: www.buscommute.com. 
 
REGIONAL TRANSFER POLICY 
A transfer slip is issued only when fare is paid. It is good until the 
date and time shown (App. 90 minutes from the last time point). 
Round trips may be made during this time. A transfer may be used to 
connect to any regular MTS bus, tram, coach and train connection. 
Upgrades may be required. 
 
SENIOR CITIZEN/DISABLED PASSENGERS: must show proof of 
eligibility (driving licence, DVLA Senior Citizen/Disabled card, pension 
or concessions cards upon request. 
 
FAREBOXES: accept £1 notes, coins but do not give change. 
PRIORITY SEATING: at the request of the driver, please reserve the 
seats at the front of the bus for Senior citizens and the Disabled. 
 
ANIMALS: Trained guide dogs my accompany persons with 
disabilities. Other animals must be in an enclosed carrier and 
transported without assistance by the driver or operator. The carrier 
must be places on the passenger’s lap or under a seat. 
THE TRANSIT STORE: 102 Broadway at 1st street, 234-1060 
(weekdays 8:30AM-5:30PM, weekends Noon- 4:00PM). Passes, 
tickets, tokens, schedules, lost & found, ID cards 9weekdays 9:00AM-
4:30Pm, weekends Noon to 3:00PM). Closed Holidays. 
 
HOW TO USE THE BIKE BUS 
When preparing to board a bike bus, make certain the driver knows 
you want to place your bike in the rack which is located at the front 
of the bus. Place both wheels of the bike in an upright position in the 
rack provided. Secure your bike in place. There is no charge for use 
of the bike rack. When removing your bike from the bike rack, again, 
make certain the driver knows you wish to remove your bike. 
Metropolitan Transit does not assume any responsibility for 
improper loading or use of the bike rack. 
The schedules and other arrangements shown in the timetable are 
 
 
Pine St. Bus Station 
Heron Ave. Bus Station 
 
 
September 1, 2011 
 
All buses are provided with bike racks 








subject to change. Metropolitan Transit does not assume 
responsibility for errors in timetables, nor for any inconvenience 


















Fares and Schedules Subject to Change 
 
FARES – Exact fare, please 
 
Basic £2.00 
Senior Citizen/Disabled £1.00 




(11 tokens for the price of ten) 
Tokens are good for fare only on buses 
 
Monthly Ready Pass £54.00 
Senior Citizen/Disabled £13.50 
Youths (18 and under) £26.00 
 
(ID may be requested) 
@ Discounted passes made possible by Transnet 
 
 When transferring to a route with a higher cash fare of 
monthly pass then originally paid, an upgrade for the 
difference is required. Upgrades may be paid on the 
original or connecting vehicle. Senior Citizen/Disabled 
passengers pay no upgrades. 
Take advantage of Two Special Offers for Friends and Family! 
 
Family Weekends – Two children (12 years old and under) travel for 
free with all adult (18+) fare paying passengers every weekend. 
 
Friends travel for free on selected holidays when one person pays by 
cash, ticket or token or uses a Ready Pass, a friend gets the same full 
journey free. Look out for Friends Travel for Free on New Years Day, 
Public Holidays and Christmas. 
INFORMATION: for trip planning and other information 0141-242-
3456; (TTY/TDD for hearing impaired, 0141-323-7890); InfoExpress, 
24-hour departure information via touch time phone, 0141-798-
3223. MTS Online: www.buscommute.com. 
 
REGIONAL TRANSFER POLICY 
A transfer slip is issued only when fare is paid. It is good until the 
date and time shown (App. 90 minutes from the last time point). 
Round trips may be made during this time. A transfer may be used to 
connect to any regular MTS bus, tram, coach and train connection. 
Upgrades may be required. 
 
SENIOR CITIZEN/DISABLED PASSENGERS: must show proof of 
eligibility (driving licence, DVLA Senior Citizen/Disabled card, pension 
or concessions cards upon request. 
 
FAREBOXES: accept £1 notes, coins but do not give change. 
PRIORITY SEATING: at the request of the driver, please reserve the 
seats at the front of the bus for Senior citizens and the Disabled. 
 
ANIMALS: Trained guide dogs my accompany persons with 
disabilities. Other animals must be in an enclosed carrier and 
transported without assistance by the driver or operator. The carrier 
must be places on the passenger’s lap or under a seat. 
THE TRANSIT STORE: 102 Broadway at 1st street, 234-1060 
(weekdays 8:30AM-5:30PM, weekends Noon- 4:00PM). Passes, 
tickets, tokens, schedules, lost & found, ID cards 9weekdays 9:00AM-
4:30Pm, weekends Noon to 3:00PM). Closed Holidays. 
 
HOW TO USE THE BIKE BUS 
 
When preparing to board a bike bus, make certain the driver knows 
you want to place your bike in the rack which is located at the front 
of the bus. Place both wheels of the bike in an upright position in the 
rack provided. Secure your bike in place. There is no charge for use 
of the bike rack. When removing your bike from the bike rack, again, 
make certain the driver knows you wish to remove your bike. 
Metropolitan Transit does not assume any responsibility for 
improper loading or use of the bike rack. 




Main St. Bus Station 
5th St. Bus Station 
 
 
September 1, 2011 
 
All buses are provided with bike racks 








subject to change. Metropolitan Transit does not assume 
responsibility for errors in timetables, nor for any inconvenience 
























UPSA - FINANCIAL SKILLS:  COUNTING CHANGE 
Real money total: £4.03 
√ 1 ten pound note * FAKE 
√ 1 five pound note * FAKE 
√ 3 one pound coins  
√ 1 twenty pence piece 
√ 4 ten pence pieces 
√ 7 five pence pieces 
√ 8 pennies 
 
 Money counted and signed by 
Neuropsychology staff and ward staff 
Date Start of session End of session 
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     


































































Appendix 2.9 – Feedback form 
 
CACR Training Feedback Questionnaire  
 
We would like you to answer some questions about the training that you have participated in. 
The results will be used to plan future training.  We do not ask for any identifying information 
and your response will remain anonymous.   
 
Please circle your answer. 
 
1. How much did you enjoy these sessions? 
 
1  2  3  4  5 
 
Did not enjoy at all       Really enjoyed 
 
 
2. Did you find the Training sessions? 
 
1  2  3  4  5 
 
Not at all interesting       Highly  interesting 
 
 
3. Do you feel that you the training has improved your ability to pay attention? 
 
1  2  3  4  5 
 
No, no at all        Yes, lots 
 
 
4. Do you feel that you the training has improved your memory? 
 
1  2  3  4  5 
 
No, no at all        Yes, lots 
 
 
5. Was the length of sessions?  Please tick the appropriate box 
 
 
Too short  Just right   Too long  
 
 
6. Was the number of sessions per week right? 
 
 
Too few  Just right   Too many 
 
   









How much did you enjoy each of the following activities? 
 
7. Alertness Training 
 
 
1  2  3  4  5 
Did not enjoy at all       Really enjoyed 
 
 




1  2  3  4  5 
Did not enjoy at all       Really enjoyed 
 
 




1  2  3  4  5 
Did not enjoy at all       Really enjoyed 
 








10. Focused Attention Training 
 
1  2  3  4  5 
Did not enjoy at all       Really enjoyed 
 




1  2  3  4  5 
Did not enjoy at all       Really enjoyed 
 
 




1  2  3  4  5 
Did not enjoy at all       Really enjoyed 
  
 








Please answer the following questions about the Computer Training: 
 
 































In the future, how likely would you be to recommend Cogniplus Training to other patients?  
 
 
1  2  3  4  5 
 
Would definitely not recommend     Would definitely recommend 
 




Appendix 2.10 – Research phase approval documents 









Letter from the State Hospital R&D Manager confirming conditional approval 
Dr Suzanne O'Rourke 
Consultant Forensic Clinical Neuropsychologist 








Re: Research Proposal: A pilot study to examine the efficacy of Computer Assisted 
Cognitive Remediation in mentally disordered offenders. 
 
Many thanks for your research proposal that was reviewed by the TSH Research Committee 
on Thursday the 31
st
 of May 2012. The committee found the proposal to be an interesting 
piece of work, and are happy to approve the study subject to a few minor clarifications. 
These are as follows: 
 
 The lengthy assessment process for each participant is of concern and this needs to 
be explained more fully in the information sheet. 
 The study requires evidence of line manager sign off, and given study history the 
committee would like the proposal to be seen and supported by the Senior 
Management Team. 
 The proposal does not address ethical approval requirements or intended process to 
define ethical approval requirements. 
 No details are provided on the manner in which the study data will be analysed, or 
the way in which attribution can be defined to CACR given range of other 
interventions ongoing with the patient participants. 
 The committee are concerned that there is a high likelihood of sample attrition given 
the lengthy assessment requirements and would like to know how the study team 
intend to address this given that the study employs a small sample size to start with.  
 The committee would also be keen to see a simple study timetable with planned stat 
and ends dates built in and linked to study stages. 
 
The committee also appreciates that the psychology dept are keen to commence the cognitive 
remediation work, and are subsequently willing to approve the study out with the regular 
research committee meetings as long as the clarifications and actions above are addressed. If 
you require any further assistance, or have any feedback on the Research approval process 









Research & Development Manager  








Email from the State Hospital R&D Manager confirming conditions have been met 
 
From: Pitcairn Jamie (STATE HOSPITALS BOARD FOR SCOTLAND) 
Sent: 01 October 2012 12:24 
To: hartley james (STATE HOSPITALS BOARD FOR SCOTLAND); O'Rourke 
Suzanne 
(STATE HOSPITALS BOARD FOR SCOTLAND) 
Cc: Gallagher Martin (NHS LOTHIAN) 
Subject: RE: State Hospital Computer Assisted Cognitive Remediation 
- 




I have had a look over your IRAS substantial amendment and the 
amended proposal and have no initial concerns over this. The action 
you have taken directly relates to previous Research Committee 
feedback so on that basis we are grateful that you have taken the 
time to consider your options and while the CAINS takes slightly 
longer than the negative symptom part of the PANSS we appreciate 
that it is still less than was originally outlined within your 
proposal. Subsequently I am happy that you progress on this basis 








The State Hospital 
01555 840293 Ext: 4355 
  
-----Original Message----- 
From: hartley james (STATE HOSPITALS BOARD FOR SCOTLAND) 
Sent: 26 September 2012 12:22 
To: O'Rourke Suzanne (STATE HOSPITALS BOARD FOR SCOTLAND); Pitcairn 
Jamie (STATE HOSPITALS BOARD FOR SCOTLAND) 
Cc: Gallagher Martin (NHS LOTHIAN) 
Subject: FW: State Hospital Computer Assisted Cognitive Remediation 




During the approval process for CACR study The State Hospital 
Research Committee asked if the length of patients’ assessments 
might be reduced.  As part of our response to this request we 
altered our methodology to indicate that only the negative subscale 
of the Positive and Negative Syndrome Scale (PANSS) would be 
administered as was the case in some previously reported literature.  
Subsequently we have discovered that, although previous studies 
reported only negative subscale results, they had in fact 
administered the entire assessment.  It is not possible to reduce 
the length of the assessment itself to focus on negative symptoms 








and did not administer a measure of negative symptoms to patients 
during the pre control period assessment but would like to resolve 
this question before the pre-treatment assessments commence. We have 
approached the University of Edinburgh Sponsor, Ray French, who has 
indicated his approval for a proposed amendment below. 
 
We are mindful that the original request to reduce the length of 
patient assessments was a very helpful suggestion and have therefore 
identified an alternative measure which we hope will meet our needs 
as a replacement for the PANSS.  The Clinical Assessment Interview 
for Negative Symptoms (CAINS) is a new measure specifically designed 
for the assessment of negative symptoms in patients with a diagnosis 
of schizophrenia.  It is endorsed by the National Institute of 
Mental Health’s initiative ‘Measurement and Treatment Research to 
Improve Cognition in Schizophrenia’ and takes 30 minutes to 
administer.   
 
We would appreciate your approval to proceed on the basis of this 
amendment. I attach the relevant IRAS and protocol forms (with 
amended text in bold). Could you please let me know when I can 
expect to hear from you on this as we have timetabled CAINS sessions 
to run next week and would appreciate an early response. I have 
received approval to proceed from the University sponsor, Ray French 









Appendix 2.11 – Participant information sheet and consent form 
Participant information sheet 
Information Sheet  
 
A study of whether practice on ‘computer video-game like’ exercises help the 
memory, attention and social functioning of patients at the State Hospital1 
 
We would like to invite you to take part in a research study. Before you decide we would like 
you to understand why the research is being done and what it would involve for you. We will 
go through the information sheet with you and answer any questions you have. 
 
Many patients at the State Hospital find that their illnesses, previous injuries or alcohol or 
drug abuse have affected their thinking.   Many notice that they find it harder to remember 
things or concentrate. The hospital wants to try a new treatment that might help improve 
these symptoms.  It’s called Cogniplus and is just like playing a computer game.  It is 
specially designed to help patients with these difficulties.   
 
Your clinical team have referred you for this treatment which is why we have come 
along to talk about it today. 
 
To see if the treatment works we are researching it by assessing how you are before and 
after taking part.  . Please read this leaflet and ask as many questions as you would like.  
You might like to talk to your key worker about it too.   
 
Why have I been chosen? 
Your clinical team think that because of your illness or medical history you may benefit from 
this treatment. 
 
Do I have to take part? 
No, it is up to you to decide whether to take part. If you do decide to take part you will be 
asked to sign a form to say this.  Even if you sign the form you can still stop taking part at 
any time and without giving anyone a reason.   If you don’t want to take part or change your 
mind later it won’t affect the rest of the treatment or change your care in any way. 
 
What will happen to me if I take part? 
If you decide to take part you will be asked to:- 
 Complete an assessment, made up of a number of exercises and puzzles six times 
over the next 18 months.  We will spread each assessment over a few meetings so 
that we never keep you for more than an hour and will seek to minimise the amount of 
                                                          
1
 The formal title of this research is ‘A randomised controlled trial of Computer Assisted Cognitive 
Remediation in mentally disordered offenders’ 





Telephone 01555 840293 









time it takes for you to complete these exercises and puzzles. We will also meet with 
you to discuss your mood and how you are feeling about things. This will be a short 
interview lasting around 30 minutes. Research has shown that people who take part in 
these type of specialist computer games find it leads to improvements in their well 
being and motivation to do things. 
 Play the specially designed computer games in the interview room on the ward.  This 
will be for about 45 minutes every Monday, Wednesday and Friday for 14 weeks.  
 
What are the possible benefits of taking part? 
We hope that taking part in the treatment will improve your memory, concentration, how 
good you are at working things out and how you get on with other people.  By taking part you 
will also help us know if the treatment works and whether the hospital should buy enough 
systems to offer it to everyone.   
 
Will my taking part in this study be kept confidential? 
Yes, All information you provide to us will be kept confidential.  The results will be put into 
your notes and a summary sent to your clinical team. Only the researchers and your clinical 
team will have access to this information.  The confidentiality of participants' personal data 
will be respected and protected in line with Data Protection Act 1998. 
 
Your name, and anything that lets us know who you are, will be deleted before we look at 
the results to see if the treatment works. 
 
What will happen to the results of the research study? 
The results will be reported back to the hospital so that they know whether the treatment 
works and should be offered on all the wards. The results will also be included in two clinical 
psychology theses which will be stored in the University of Edinburgh’s Library and in journal 
articles.   Apart from the notes in your files, your name will not be on anything so no one will 
know that you took part or what your results were.   
 
After your first assessment you will be given a summary of your results that you can keep.  
We will help you update this each time you are re-assessed and discuss how you are doing 
with you.  You will also receive feedback on how well you are doing every time you use the 
computer.  At the very end of the project we will describe our findings about whether the 
treatment works at the ward meeting. 
 
Who is organising and funding the research? 
The research is being conducted by the hospital as part of the neuropsychology service by 
two students who will use the results for their studies. 
 
 
Who has reviewed the study? 
The State Hospital Research Committee and the [South East Scotland] Research Ethics 
Committees have reviewed this study. 
 
 
Contact for Further Information 
If you would like any further information or have any questions please do not hesitate to 
contact us: James Hartley/Martin Gallagher on (x4473)  or our supervisor Dr Suzanne 








Thank you for taking the time to read this. 
Participant consent form 
Patient Identification Number for this trial: 
CONSENT FORM 
 
Title of Project: A pilot of Computer Based Cognitive Rehabilitation 
in mentally disordered offenders. 
 
Name of Researchers: James Hartley/Martin Gallagher   Please Initial 
 
1. I confirm that I have read and understand the information sheet dated 
25/06/2012 for the above study.   I have had the chance to consider  
the information,  ask questions and have had these answered so that I 
now feel I understand everything. 
 
 
2. I understand that it is up to me whether I take part and that I can drop out 




3. I understand that the researchers need to look at my medical notes if it is 
needed for the research.  I give permission for the researchers to have 
access to my records. 
 
 
4. I agree to my RMO being informed about my participation  








_______________    ________________ _________________ 












Telephone 01555 840293 










_________________                     ________________  ___________________ 
Name of Person taking consent Date     Signature 
 
 
Appendix 2.12 – Service evaluation phase approval documents 


















Letter informing the State Hospital Research Committee of Service Evaluation 
Mr Jamie Pitcairn, 
R&D Manager 











Subject:  Major Amendment 
Re:  Research proposal for the study; “A Randomised Controlled 
Trial of Computer Assisted Remediation in MDOs”. 
 
Further to our initiation of the above study on Arran hub I write to provide the 
Research Committee with both a progress report, attached, and a proposal to amend 
our approach to that of a service evaluation rather than a research project. 
 
A full outline of our progress to date is provided but, suffice to say, we have 
encountered a range of difficulties that have led us to conclude that a research project 
of the standard we had aspired to, with either a control group or control period, 
appears unlikely to succeed in The State Hospital at this time. 
 
Given that at the end of the current project, (end January 2013) we will still have 
more than a year of product licence remaining we are keen that this be put to good 
use.  Our suggestion is that CACR becomes part of the hospital’s current menu of 
treatments and that a simple service evaluation is undertaken to provide some 
evidence with regard to its efficacy.   
 
As a standard hospital treatment referrals would be invited from suitable patients.  
Patients would be asked if they would like to participate as they would for any other 
treatment to which they are referred but would not be asked to provide written 
consent.  There would be no control period or additional assessments to identify if 
patients’ current functioning is stable.  Patients agreeing to participate in treatment 
would be asked to complete assessment measures before and afterwards and at fixed 
time points subsequently, as they would for other psychological therapies, to evaluate 
their personal progress.  The assessments will be same as, or reduced in number, 
those identified as suitable during our original proposal as these are also most 
suitable for identifying individual progress. The treatment provided will be similar to 
that suggested in our previous proposal and conducted either on the wards as 
currently or perhaps in the learning centre (discussions are due to take place in 
January).   Should sufficient data be collected a service evaluation will attempt to 








any gains were sustained.  With appropriate permissions, routinely collected data 
could also form part of these analyses. 
 
Although we acknowledge that as a service evaluation the methodology is far less 
robust than we would have hoped we still anticipate the results forming part of 















Email from the State Hospital R&D Manager confirming approval of service evaluation 
From: Pitcairn Jamie (STATE HOSPITALS BOARD FOR SCOTLAND) 
Sent: 29 April 2013 11:28 
To: Alcock Duncan (STATE HOSPITALS BOARD FOR SCOTLAND); Gallagher 
Martin (NHS LOTHIAN) 
Subject: RE: Caldicott Approval 
 




I have had a quick look back over the paperwork for this study. The 
study was originally approved without the inclusion of the 
additional use of routinely collected data. However the study lead 
Dr Suzanne O’Rourke did submit a letter of amendment to the research 
committee indicating that there was a desire to utilise routinely 
collected clinical data to assist in the evaluation of the efficacy 
of the CACR pilot programme. The amendment was noted by the Research 
Committee and the need for caldicott guardian approval for the use 
of routine data reiterated, although I should say that Dr O’Rourke 
had made clear the intention to seek Caldicott approval. So in that 
sense the TSH Research Committee are satisfied that the research 
approval aspects have already been addressed, but that Caldicott 
Guardian approval should be sought for the additional use of 





I hope this sounds reasonable Duncan, and perhaps I need to copy you 
into any future correspondence that recommends (or requires) that 
the Caldicott guardian should be approached, as standard practice. 















The State Hospital 
 








Email from the State Hospital Caldicott Guardian confirming approval 
From: Gallagher Martin (NHS LOTHIAN) 
Sent: 20 May 2013 16:48 
To: Alcock Duncan (STATE HOSPITALS BOARD FOR SCOTLAND) 




Thanks very much for this.  I can confirm that it will only be 
myself and Suzanne that will have the list that matches the patients 








From: Alcock Duncan (STATE HOSPITALS BOARD FOR SCOTLAND)  
Sent: 10 May 2013 16:18 
To: Gallagher Martin (NHS LOTHIAN) 
Cc: O'Rourke Suzanne (STATE HOSPITALS BOARD FOR SCOTLAND) 




This addresses any concerns I may have had. Only one further thing 
comes to mind and that is who will hold to list that matches the 
patients to the identification number. If this is only you and 







Dr Duncan Alcock 
 
Consultant Forensic Psychiatrist/ Joint Associate Medical Director/ 
Caldicott Guardian/ Lewis Hub Clinical Lead 
 
The State Hospital 
  
 
Clinical/ Lewis Hub Matters Tel 01555 842044 
 





From: Gallagher Martin (NHS LOTHIAN)  
Sent: 10 May 2013 10:00 
To: Alcock Duncan (STATE HOSPITALS BOARD FOR SCOTLAND) 










Below is an amended version of the parts of my uni ethics form that 
relate to information governance.  Please let me know if there is 
any other information you need and I will pass this on. 
 





How will the confidentiality of data, including the identity of 
participants (whether specifically recruited for the research or 
not) be ensured? 
 
All assessments form part of patients’ clinical records and will be 
stored on RiO, The State Hospital’s electronic record system. 
 
No identifiable information will be stored on the database created 
for the analysis of data (see below for details).  All patients will 
be assigned an identification number for the purposes of the 




Who will be entitled to have access to the raw data? 
 
As this is a service evaluation and the assessments form part of 
patients’ clinical record, the data can be accessed by anyone at The 
State Hospital involved in the patients’ care and treatment, with 
the exception of neuropsychology data which will only be accessible 
to psychology staff involved in their care and treatment. 
 
Data will also be available to Martin Gallagher (Trainee Clinical 
Psychologist), Dr Suzanne O’Rourke (Consultant Forensic Clinical 
Neuropsychologist) and James Hartley to allow this to be analysed as 
part of the service evaluation.  James Hartley is an Edinburgh 
University research student who has an honorary contract with The 
State Hospital and will be involved in evaluating the service.  Mr 
Hartley will only have access to anonymised data. 
 
  
What process will be used to access existing data? 
 
PECC, CORE, BEST and DATIX information will be accessed by Martin 
Gallagher via The State Hospital’s records.  This information will 
then be fully anonymised and stored in the database (see below). 
  
 
How and where will the data be stored, in what format, and for how 
long? 
 
Data will be stored in two locations: 
 
1. In accordance with standard practice within the hospital, raw 








to allow relevant clinical staff to access the information.  This 
will take the form of electronic scans of recording forms for the 
various measures.  This data will remain part of the clients’ 
medical records. 
 
2. Fully anonymised data will also be stored in a database located 
on a shared, secure drive within The State Hospital network.  This 
will allow the information to be analysed as part of the service 




What steps have been taken to ensure that only entitled persons will 
have access to the data? 
 
The State Hospital’s information security policies and procedures 
ensure that access to patients’ records via RiO is only granted to 
individuals within the hospital who have a genuine need to view the 
information. 
 
IT have ensured that the shared network drive is only accessible to 
individuals directly involved in delivering and evaluating the 
treatment.  This drive is not accessible outwith The State Hospital. 
  
 
How will the data be disposed of? 
 
The anonymised data stored on the shared drive will be deleted after 
10 years, in accordance with the relevant guidelines. 
  
 
How will the results of the research be used? 
 
The results of the study will be used to evaluate the efficacy and 
feasibility of computer assisted cognitive remediation (CACR) within 
a high secure forensic hospital.  This will help management staff 
within the hospital to decide whether or not to invest further in 
CACR as part of the available treatments within the hospital. 
 
It is anticipated that the results will also be published in a 
relevant journal and form part of the doctoral theses of Martin 






From: Alcock Duncan (STATE HOSPITALS BOARD FOR SCOTLAND)  
Sent: 30 April 2013 10:34 
To: Gallagher Martin (NHS LOTHIAN); Pitcairn Jamie (STATE HOSPITALS 
BOARD FOR SCOTLAND) 











All would I need in this instance is something in writing 
documenting the Information Governance safeguards that will be in 
place for this project. In particular how you will protect the 
confidential patient information that will be collected for this 
project. It is likely this was previously covered in the original 
research proposal so it shouldn't require you to start from scratch. 
Suzanne will be able to provide assistance with this if needs be as 






Dr Duncan Alcock 
 
Joint Associate Medical Director/Consultant Forensic 
Psychiatrist/Caldicott Guardian 
 
The State Hospital, Carstairs 
 






From: Gallagher Martin (NHS LOTHIAN) 
Sent: 29 April 2013 11:36 
To: Pitcairn Jamie (STATE HOSPITALS BOARD FOR SCOTLAND); Alcock 
Duncan (STATE HOSPITALS BOARD FOR SCOTLAND) 
Subject: RE: Caldicott Approval 
 
Dear Jamie, Duncan, 
 
Many thanks for your replies. 
 
Duncan, if there is any information that you require for this then 
please let me know. 
 






From: Pitcairn Jamie (STATE HOSPITALS BOARD FOR SCOTLAND)  
Sent: 29 April 2013 11:28 
To: Alcock Duncan (STATE HOSPITALS BOARD FOR SCOTLAND); Gallagher 
Martin (NHS LOTHIAN) 
Subject: RE: Caldicott Approval 
 
Dear Duncan, Martin, 
 
I have had a quick look back over the paperwork for this study. The 
study was originally approved without the inclusion of the 








Dr Suzanne O’Rourke did submit a letter of amendment to the research 
committee indicating that there was a desire to utilise routinely 
collected clinical data to assist in the evaluation of the efficacy 
of the CACR pilot programme. The amendment was noted by the Research 
Committee and the need for caldicott guardian approval for the use 
of routine data reiterated, although I should say that Dr O’Rourke 
had made clear the intention to seek Caldicott approval. So in that 
sense the TSH Research Committee are satisfied that the research 
approval aspects have already been addressed, but that Caldicott 
Guardian approval should be sought for the additional use of 
clinical data collected for the purpose of ongoing care and 
treatment.  
 
I hope this sounds reasonable Duncan, and perhaps I need to copy you 
into any future correspondence that recommends (or requires) that 
the Caldicott guardian should be approached, as standard practice. 












The State Hospital 
 





From: Alcock Duncan (STATE HOSPITALS BOARD FOR SCOTLAND)  
Sent: 25 April 2013 16:44 
To: Gallagher Martin (NHS LOTHIAN) 
Cc: Pitcairn Jamie (STATE HOSPITALS BOARD FOR SCOTLAND) 




It would appear to me that what you are suggesting is a new piece of 
research in relation to the cognitive remediation therapy that is 
occurring in the hospital. As a first point I would suggest running 
this past Jamie Pitcairn (Research and Development Manager) to get 

















Consultant Forensic Psychiatrist/ Joint Associate Medical Director/ 
Caldicott Guardian/ Lewis Hub Clinical Lead 
 




Clinical/ Lewis Hub Matters Tel 01555 842044 
 





From: Gallagher Martin (NHS LOTHIAN)  
Sent: 08 April 2013 13:16 
To: Alcock Duncan (STATE HOSPITALS BOARD FOR SCOTLAND) 
Subject: Caldicott Approval 
 
Dear Dr Alcock, 
 
As part of my training in clinical psychology, I am completing a 
research project that is looking at the efficacy of computer 
assisted cognitive remediation therapy.  We are hoping to use the 
data from patients’ existing PECC assessments to inform our analysis 
of psychotic symptoms.  I understand I will require Caldicott 
approval for this. 
 
I am wondering if there is a standard procedure/application form for 
applying for approval?  If it would be helpful I can forward on my 
research proposal document. 
 







Trainee Clinical Psychologist 
 
  
 
 
